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Fmoc-B-Ala-F fluorenylmethoxycarbonyl-β-alanine acid fluoride
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Molecular capsules consist of two or more molecules that bind through either
covalent or noncovalent interactions to form a structure with an internal void capable of
containing guest molecules. These capsules can be used in catalysis/biocatalysis, in drug
transport and delivery, in supramolecular arrays, and to stabilize reactive intermediates.
Cavitands and calix[4]arenes are two types of macrocycles that have been used to form
molecular capsules. Cavitands are used to form capsules called carceplexes,
hemicarceplexes, and hemicarcerands through covalent bonds when two molecules are
bridged together rim to rim. Calix[4]arene derivatives self-assemble reversibly through
noncovalent interactions such as hydrogen bonding and ionic bonding to form capsules.
Capsules formed form cavitands and calix[4]arenes have been shown to encapsulate a
variety of guest molecules in nonpolar solvents. In order for the capsules to be used for
biological applications, the capsules need to encapsulate guest molecules in water. There
are only a few examples of capsules that encapsulate guests in polar solvents.
Calix[4]arenes derivatives substituted with charged substituents on the upper rim
and propyl groups on the lower rim were synthesized. These derivatives dimerize through
ionic interactions in polar solvents forming both heterodimers and homodimers. These
dimers will be used to encapsulate various guest molecules. Although of the ionic
propoxycalix[4]arene monomers are water-soluble, the dimers are not. This is due to the
shielding of the charges upon assembly leaving only the propyl groups on the lower rim
exposed to the polar solvent. To increase dimer solubility in water, calix[4]arene
derivatives are being synthesized with hydroxy ethyl groups instead of the propyl groups
xxvi
on the lower rim. When the charged hydroxyethoxycalix[4]arene derivatives dimerize,






Molecular capsules consist of two or more molecules that bind through either
covalent or noncovalent interactions to form a structure with an internal void capable of
containing guest molecules. These capsules can be used in catalysis/biocatalysis, in drug
transport and delivery, in supramolecular arrays, and to stabilize reactive intermediates.
Cavitands and calix[4]arenes are two types of macrocycles that have been used to form
molecular capsules. Cavitands are used to form capsules called carceplexes,
hemicarceplexes, and hemicarcerands through covalent bonds when two molecules are
bridged together rim to rim. Calix[4]arene derivatives self-assemble reversibly through
noncovalent interactions such as hydrogen bonding and ionic bonding to form capsules.
Capsules formed form cavitands and calix[4]arenes have been shown to encapsulate a
variety of guest molecules in various solvents.
1.2 Carceplexes, Hemicarceplexes, and Hemicarcerands
Cavitands are macrocyclic compounds composed of four resorcinols connected by
methylenes that are synthesized by condensation of the resorcinols with aldehydes















Scheme 1-1.  Synthesis of Cavitands
When an appropriate guest molecule is present in solution, cavitands self-assembly
around the guest. These capsules can then be covalently linked rim-to-rim forming
carceplexes and hemicarceplexes. Carceplexes are carcerands that contain a guest
molecule that is encapsulated irreversibly when the carcerand is formed (Figure 1-1).
Hemicarceplexes encapsulate guest molecules at ambient temperatures but release the
guests at elevated temperatures (Figure 1-1).
Through molecular mechanics calculations, Houk et al. propose that “gates”
control the encapsulation and release of guests in some hemicarcerands.3 They proposed
two types of gates, french doors and sliding doors. The French door gate opens and closes
through chair-to-boat transitions of the methylenes of the cavitands. The sliding door gate
opens and closes through conformational changes between the polar caps (cavitands) and
the connecting bridges. The authors identified three types of host-guest carcerand
complexes. The first type of complex, a carceplex, consists of a host with portals that are
too small to allow guest entry or release. These complexes must be formed during
synthesis of the carceplex and the guest is usually a solvent molecule. The second type of
complex, a hemicarceplex, consists of a host with portals larger than the guests. In these
complexes, guests move easily in and out of the host making it impossible to isolate and
characterize the complex. The third and last type of complex, also a hemicarceplex,
3
contains portals that are smaller than the guests and do not allow passage into or out of
the host until a conformational change occurs that opens the gate, increasing the size of
the portal allowing the guest to enter or exit. Without gating, only molecules of similar







Figure 1-1.  Carceplex and Hemicarceplex Structures
4
1.2.1 Carceplexes
Carceplexes consist of a hosts with portals that are too small to allow guest entry
or release. These complexes must be formed during synthesis of the carceplex and the
guest is usually a solvent molecule. Sherman and Cram4 synthesized carceplexes that
encapsulated one solvent molecule when the carcerand was synthesized. The synthesis of
the carceplex required a guest of adequate size to act as a template and bring the two
cavitand halves together so the bridges could be attached. Sherman et al.5 used several
molecules to probe the templating effects of the guest molecules on capsule formation.
They found that carceplex 1 (Figure 1-2) is big enough to encapsulate molecules that are






















Figure 1-2.  Carceplex Structure
5
The largest and poorest guest that was encapsulated is 1-methylpyrrolidin-2-one.
Competition experiments with various guests versus 1-methylpyrrolidin-2-one were
carried out (Table 1-1). The capsule preferred guests with moderate polarity ranging from
benzene to dimethyl sulfoxide (DMSO). Anything with either high (water) or low
(cyclopentane) polarity was unsuitable as a guest for the carcerand synthesis.
Symmetrical molecules were found to be better templates than nonsymmetrical
molecules. Cyclic molecules were found to be better then acyclic molecules. No
secondary amines were encapsulated. The guest with the best templating ability was
pyrazine.
6
Table 1-1.  Carceplex Yields and Competition Experiments
guest yield (%)a ratiob conditionsb
pyrazine 87 1000000 A
1,4-dioxane 68 290000 A
dimethyl sulfide 52 180000 A
dimethyl sulfoxide 63 70000 A
1,3-dioxolane 64 38000 A
2-butanone 75 37000 A
pyridine 46 34000 A
dimethyl sulfone 60 19000 A
furan 54 12000 A
tetrahydrofuran 50 12000 A
acetone 51 6700 A
thiophene 23 5800 A
benzene 43 2400 A
2-propanol 74 1500 A
pyrrole 73 1000 B
tetrahydrothiophene 34 410 B
1,3-dioxane 45 200 B
acetamide 26 160 B
trioxane 24 100 B
acetonitrile 35 73 B
ethanol 38 61 B
dimethylacetamide 15 20 B
dimethylformamide 4 7 B
NMP 5c 1 B
aYield refers to the reaction run with one guest only. bA: 1 mol% guest. B: 5
mol% guest, 1 day at 25 °C, 2 days at 60 °C. cReaction was run in 100% NMP.
7
1.2.2 Hemicarcerands and Hemicarceplexes
Hemicarceplexes contain portals that are smaller than the guests and do not allow
passage into or out of the host until a conformational change occurs that increases the
size of the portal allowing the guest to enter or exit. The synthesis and study of various
different hemicarcerands is an ongoing project for Dr. Donald Cram and his research
group. They have synthesized several hemicarcerands containing different bridging
linkers (Figure 1-3). The first hemicarcerand synthesized (2) was connected by three
methylene bridges and was studied for its ability to encapsulate and release various
guests.6 The term constrictive binding was used to define the energy barrier from the
opening and stretching of the portal that must be overcome for a guest to enter or exit the
capsule. This barrier leads to stable hemicarcerands/hemicarceplexes that do not allow
guests to enter or leave the capsule at room temperature but do allow guest entry or
release at elevated temperatures. Hemicarcerand 2 was found to bind N2, O2, H2O, and
CO2 at room temperature with free energies of –2 to –3 kcal/mol but the hemicarceplexes
were not isolatable. Compound 2 was able to encapsulate CS2, Xe, CH3CN, CH2Cl2,
CH2Br2, and CS2 in solution at room temperature and the hemicarceplexes were isolated
and characterized. When 2 was heated in large solvents, such as pyridine, benzene,




























































Figure 1-3.  Hemicarcerand Structures
9
Four rigid 1,3-di(methylimide)benzene spacers were used to synthesize a larger
hemicarcerand 3 (Figure 1-3).7 It was found to encapsulate large guest molecules such as
hexachlorobutadiene, triethyl phosphate, tripropyl phosphate, menthol, anthraquinone,
hexamethylphosphoramide, anthracene, camphor, ferrocene, ruthenocene, amantadine,
hexamethylenetetramine, adamantane, and [2.2]paracyclophane at elevated temperatures.
All of these hemicarceplexes were isolatable and characterizable at room temperature.
1,3-Dimethylbenzene connecting bridges were used to synthesize hemicarcerand
4 that was more flexible then the rigid 1,3-di(methylimide)benzene bridged
hemicarcerand 3 (Figure 1-3).8 Compound 4 was found to exist in two forms, open and
closed (Figure 1-4). In the open form, the polar caps are symmetrically aligned with one
another and the portal is opened wide enough to allow entry and release of guest
molecules. In the closed form, one polar cap is rotated 21 ° compared to the other. This
rotation brings the polar caps closer together and shrinks the size of the portal locking in
any guest molecules. The hemicarcerand was found to adopt the closed form at room
temperature but the energy barrier required for the hemicarcerand to untwist and open
was overcome at elevated temperatures (~100 °C). Several guests were encapsulated at
elevated temperatures such as ethylbenzene, 1,4-dimethylbenzene, tetrachloroethane,
dimethylaminomethylketone, dimethylformamide (DMF), acetonitrile, 1-butanol,
ethylmethylketone, ethylacetate, THF, toluene, and chloroform. The decomplexation
rates and half-life’s for these complexes are listed in Table 1-2. Interestingly, both the
shape and size of the guest influenced encapsulation. For example, p-Xylene was
encapsulated but m-xylene and o-xylene were not.
10
Table 1-2.  Dependence of Decomplexation Rates on Guest Structure of 4:Guest in
CDCl2 at 100 °C










ethyl acetatea 409 0.28
aEstimated from rate constant at 130 °C assuming it decreased by a factor of 3 in































     Untwisted-Open Form         Twisted-Closed Form
Figure 1-4.  Dimethylbenzene Bridged Hemicarcerands
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Hemicarcerand 5 (Figure 1-3), containing four butane connecting bridges, was
synthesized by Cram et al.9 The more flexible butane derivative was found to bind a
wider variety of guests, and bound them tighter than the 1,3-dimethylbenzene derivative
(4). Compound 5 was found to bind guests of various sizes ranging from Xe to
iodoethane to disubstituted toluenes. Similar to hemicarcerand 4, 5 was found to adopt
three different conformations: untwisted-open, untwisted-closed, and twisted-closed. In
the first conformation, the lone pairs on the eight oxygen atoms connected to the bridges
point outward and the bridges point inward. The second conformation is the opposite
with the lone pair pointing in and the bridges pointing out. In this conformation, the two
polar caps can twist about 15 ° with regard to each other. As seen before, this pulls the
polar caps closer together and shrinks the portal and cavity size. The shape and alignment
of the guest greatly influences the ability of the hemicarcerand to twist. The
nonsymmetric acyclic compounds and the more substituted aromatic compounds prevent
twisting of the polar caps. When twisting was prevented by the guest, the host was still
able to minimize the cavity size by rotating the butane bridges perpendicular to the plane














































Figure 1-5.  Butane Bridged Hemicarcerands
13
Hemicarcerands containing large portals were also synthesized.10 These
hemicarcerands contained either four 2,4-hex-diyne connecting bridges (6) or four
hexane connecting bridges (7) (Figure 1-6). The triple bonds of the 2,4-hex-diyne
hemicarcerand were reduced to form the hexane bridged hemicarcerand, which could not
be synthesized directly due to the intramolecular reaction of the linker with the adjacent
hydroxyls. Compound 6 was found to encapsulate hydrocarbons with molecular weights
up to 236 g/mol such as 1,3,5-triethylbenzene, 1,3-dimethyladamantane,
[3.3]paracyclophane, 4-ethyl[2.2[paracyclophane, and three disubstituted
[2.2]paracyclophanes. Encapsulation studies on the more flexible hexane bridged


























Figure 1-6.  Large Portal Hemicarcerands
14
1.2.3 Asymmetric and Water-Soluble Hemicarcerands and Hemicarceplexes
Two asymmetric hemicarcerands containing three butane connecting bridges and
one chiral connecting bridge have been synthesized.11 One of the chiral bridges is an
acetonide ring (8) and the other is a 2,2’-bisoxymethylene-1,1’-binapthyl moiety (9)
(Figure 1-7). These hemicarcerands were studied for their ability to selectively bind
chiral guests. The binapthyl bridged hemicarcerand (9) was able to bind only one guest,
(R)-4-methyl-p-tolylsulfoxide, with high selectivity (>20:1). Other guests were
encapsulated with ratios ranging from 2.7:1 to 1:1. The acetonide bridged hemicarcerand
was found to have lower selectivity than the binapthyl bridged capsule.
In order to be used in biological systems, water-soluble capsules are needed.
Hemicarcerand 10a containing four 3,5-dimethyl-2,6-dicarboxylicacidbenzene
connecting bridges was synthesized (Figure 1-7).12 This octaacid hemicarcerand was
found to be water soluble and to encapsulate several guest molecules in D2O at pH 9.
Additionally, 10a was able to bind 1,4-dimethylbenzene and 1,4-dimethoxybenzene
better in D2O than the non water-soluble benzyl bridged hemicarcerand 10b in CDCl3.
Hemicarcerand 10a was not able to encapsulate lipophilic salts such as
tetramethylammonium bromide, trimethylphenylammonium bromide,
trimethylbenzylammonium bromide, and sodium 3-methylbenzoate. The authors




































10a R = CO2H
9
10b R = H
Figure 1-7.  Asymmetric and Water-Soluble Hemicarcerands
1.2.4 Reactions within Hemicarceplexes
One application of hemicarceplexes is the stabilization and protection of reactive
guests synthesized within the capsule. Cyclobutadiene is a very reactive molecule that
was synthesized within hemicarcerand 2 from α-pyrone.13 α-Pyrone was encapsulated in
2 where it was photochemically converted into photopyrone. Upon further irradiation, the
photopyrone was converted into cyclobutadiene (Figure 1-8). The encapsulated
cyclobutadiene was stable in deoxygenated solution up to 60 °C. Previously,
16
cyclobutadiene had only been studied in cryogenic matrices below 8 K.14 With further
irradiation, the encapsulated cyclobutadiene decomposed into acetylene that easily
escaped the capsule. When the encapsulated cyclobutadiene was heated to 220 °C in
THF, cyclobutadiene was released into the solvent and dimerized to produce
cyclooctatetra-1,3,5,7-ene. Additionally, encapsulated cyclobutadiene was found to react














Figure 1-8.  Synthesis and Reactions of Cyclobutadiene in Hemicarcerand 2
1,2,4,6-cycloheptatetraene is a highly reactive molecule that has been stabilized
by encapsulation within a hemicarcerand.15 Phenyldiazirine was encapsulated in
hemicarcerand 11. Cycloheptatetraene was synthesized through a photochemical
phenylcarbene rearrangement of the encapsulated phenyldiazirine and is stable for weeks
at room temperature in solution without oxygen (Figure 1-9). Although unreactive
17
towards water and methanol even at 60 °C, the addition of oxygen to the solution
converts the cycloheptatetraene into benzene. The free cycloheptatetraene reacts rapidly
















Figure 1-9.  Synthesis of 1,2,4,6-Cycloheptatetraene in Hemicarcerand 11
Hemicarcerand 5 containing four butane bridges was also used to stabilize
reactive guests16 and as a container for through shell reactions.17, 18 o-Benzyne, another
highly reactive molecule, was previously only studied in cryogenic conditions bellow 77
K. Warmuth encapsulated benzocyclobutenedione in 5.16 The encapsulated
benzocyclobutaenedione was photochemically converted (λ > 400 nm) into
benzocyclopropenone at 77 K. The encapsulated benzocyclopropenone was stable at
room temperature for several days, and could also be photochemically converted (λ <297
18
nm) into o-benzyne at 77 K (Figure 1-10). When the o-benzyne hemicarcerand complex
was heated from 77 K to –75 °C, the o-benzyne reacted through a Diels-Alder reaction
with one of the benzene rings of the hemicarceplex.
Cram et al. studied the oxidation and reduction of encapsulated hydroquinones
and quinones (Figure 1-10) in 5.17 Several quinones were synthesized from the
encapsulated hydroquinones in quantitative yields. These quinones could not be
encapsulated due to their instability in solution at elevated temperatures and had to be
synthesized inside the capsules. The quinones were stable in the capsules up to 100 °C.
The quinones could also be reduced back to the hydroquinones quantitatively.
Interestingly, nitrobenzene encapsulated in 5 was reduced to N-hydroxyaniline with
samarium iodide and methanol in THF. Under the same conditions, free nitrobenzene is
reduced to aniline. Hemicarcerand 5 was also used to study the alkylation of various
hydroxy substituted benzenes.18 The authors found that guest orientation and reagent size
played a big part in the alkylation. The guests usually oriented themselves in the capsule
with at least one of the substituents in the polar cap. Guests, such as 2-hydroxytoluene, 3-
hydroxytoluene, and 1,3-hydroxybenzene, that contained equatorially located hydroxyls
could be methylated, but guests that contained para substituents were not methylated
because both substituents were located in the polar caps. 1,2-Hydroxybenzene oriented
itself with one hydroxyl in the polar cap and the 0other in the equatorial region allowing
























Figure 1-10.  Reactions in Hemicarcerand 5
1.3 Calix[4]arenes
Calix[4]arenes are macrocycles composed of four phenols connected through
their ortho positions by methylene bridges. They are synthesized by condensation of t-





      reflux
Scheme 1-2.  Calix[4]arene Synthesis
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Calix[4]arenes exist in four different interconverting conformations: cone, partial
cone, 1,2-alternate, and 1,3-alternate (Figure 1-11).20 The conformations interconvert by













Figure 1-11.  Calix[4]arene Conformations
The cone conformation is the most stable due to intramolecular hydrogen bonding of the
phenolic hydroxyls. Alkylating the phenolic oxygen, or lower rim, with either a propyl
group or a larger functional group prevents the calix[4]arene from interconverting
between conformations and is easily achieved through a Williamson ether synthesis. The
cone conformation is bowl shaped and contains a cavity capable of binding small guest
molecules (Figure 1-12). By functionalizing the upper rim, calix[4]arene derivatives, that
self-assemble through hydrogen or ionic bonding to form molecular capsules, can be
synthesized. Upon assembly, these capsules can reversibly encapsulate guest molecules









Figure 1-13.  Calix[4]arene Self-Assembly and Encapsulation
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1.3.1 Hydrogen Bonded Capsules in Nonpolar Solvents
Several calix[4]arene derivatives that self-assemble through hydrogen bonding to
form capsules in nonpolar solvents have been developed. Shimizu and Rebek synthesized
a phenylurea functionalized calix[4]arene derivative substituted on the lower rim with
benzyl groups (12) (Figure 1-14).21 1H NMR studies showed that 12 self-assembled into a
homodimer (12:12) in nonpolar solvents such as chloroform. The 1H NMR spectrum of
the capsule was symmetric and well resolved, which is consistent with dimer formation.
Due to the symmetry of the 1H NMR spectrum, it was deduced that the capsule must be
asymmetric with all of the ureas oriented in the same direction. The 1H NMR spectrum
also showed a high degree of hydrogen bonding. The urea protons were shifted downfield
compared to the urea protons in the spectrum of the monomer. The addition of a polar
solvent, such as DMSO, disrupts the hydrogen bonding causing the capsule to dissociate
into its monomers. 1H NMR studies showed that the homodimer was able to encapsulate
several different solvents. Competition experiments were performed with homodimer
12:12  and equimolar mixtures of  the guests.  The relative populations of
homodimer:guest complexes were compared and benzene and chloroform were found to
be the best guests followed by toluene, o-xylene, p-xylene, and ethyl benzene. The
encapsulation of the guests is size dependent with the smaller guests being bound more
tightly. Both ortho-xylene, para-xylene, and ethylbenzene are similar in size but the
capsule prefered o-xylene due to guest shape instead of guest size. Encapsulation was
also seen in the gas phase. Peaks for the complexes of the capsule with benzene,
chloroform and methylene chloride were seen by MS, but peaks for the complexes with














Figure 1-14.  Phenylurea- and Fluorophenylureacalix[4]arenes
A calix[4]arene derivative (13) with fluorophenylureas on the upper rim was
studied for its ability to encapsulate guest molecules (Figure 1-14), using 19F and 1H
NMR.22 Fluorophenylurea was used so that the fluorine atoms could act as an internal
standard for the 19F spectroscopy studies. Calix[4]arene 13 was seen to form a
homodimer in nonpolar solvents but dissociated upon addition of small amounts of polar
solvents, much like the phenylurea derivative. Addition of fluorobenzene to a solution of
the homodimer in p-xylene-d10, caused a signal to appear upfield in the 
19F NMR that
corresponded to the encapsulated fluorobenzene. Integration of the signals shows a 1:1
ratio of capsule to guest. In the 1H NMR spectrum, different peaks are seen for the ortho,
meta, and para protons of the fluorobenzene with the para protons being more than 2
ppm away from the ortho protons. This is consistent with the fluorobenzene being
oriented with the fluorine and para proton pointing at the ureas and the ortho and meta
protons being pointed towards the phenyl rings. Addition of phenyl-α-phenylethyl urea to
the solution breaks up the complex and releases the guest due to competitive hydrogen
bonding between the phenyl-α-phenylethyl and the calix[4]arene. Other guests were also
24
encapsulated including benzene, p-difluorobenzene, chlorobenzene, toluene, phenol,
aniline, pyrazine, and pyridine. Benzene was found to have an association constant of 230
M-1. The relative affinities of the guests compared to that of benzene are listed in Table 1-
3.
Table 1-3.  Relative Affinities of 13:13 for Guests in Competition with Benzenea
Guest
Affinity











aConcentration of dimer is 2.936 x 10-3 M; guest and benzene concentrations are
21.94 x 10-3 M each. bA precipitate formed after several hours.
More flexible calix[4]arene derivatives (Figure 1-15) with methoxy groups on the
lower rim and substituted ureas on the upper rim have also been synthesized.23 The ureas
were substituted with toluene (14), fluorobenzene (15), or octane (16). The methoxy
groups on the lower rim are not large enough to lock the derivative in a single
conformation, making the derivatives more flexible then the previous examples 12 and
13. Each derivative exists in all of the conformations with the partial cone conformation
(96%) being the most favorable. For all of the dimers studied, the energy gained from the
formation of 16 hydrogen bonds during dimerization was high enough to overcome the
energy barrier needed (~13 kcal) for the derivative in the partial cone form to convert into
the cone form. Derivatives 14 and 16 were combined in a 50/50 ratio and studied by 1H
25
NMR. The 1H NMR spectrum revealed peaks for three different dimers, two homodimers























Figure 1-15.  Flexible Ureacalix[4]arene Derivatives
Extended calix[4]arene derivatives 17 and 18 with substituted ureas attached to
phenyl spacers on the upper rim were synthesized by Rebek et al.24 The extended
calix[4]arene derivatives were found to form homodimer 17:17, homodimer 18:18, and
heterodimer 17:18 in chloroform-d and methylene chloride-d2. The homodimer 18:18
was studied for the encapsulation of several different guests (Figure 1-16). The extra
phenyl spacers created large pores in the capsule that allowed solvent molecules to enter
and exit rapidly. No encapsulation was seen for the neutral guests (24-26) but,
encapsulation was observed for the cationic guests (19-23). The guest exchange was fast
on the NMR time scale so only a complex induced shift in the guests 1H NMR signals
was seen. The association constant for guest 19 in methylene chloride-d2 was calculated































Figure 1-16.  Extended Ureacalix[4]arene Derivatives and Guest Molecules
Dr. Bohmer's research group synthesized several different calix[4]arene
derivatives with substituted ureas on the upper rim and pentyl, benzyl, or ethyl ester
groups on the lower rim (Figure 1-17).25 All of the derivatives (27-29) were found to
form homodimers in apolar solvents and existed as monomers in polar solvents. Mixtures
composed of two of the derivatives were made in all the possible combinations and
studied by 1H NMR. When the two derivatives were mixed together in dmso-d6, the 
1H
NMR spectrum was composed of the spectra of each derivative alone. When the two
27
derivatives were mixed together in apolar solvents, the spectrum contained three sets of
signals. Two of the signals were from the two homodimers and one of the signals was
from the heterodimer. The two homodimers and the heterodimer were found to exist in






























Figure 1-17.  UreaCalix[4]arene Derivatives
Calix[4]arene derivative 30, with propyl groups on the lower rim and tolyl ureas
on the upper rim, was used to study the effects of the size and shape on the encapsulation
of cationic guests (Figure 1-18).26 Several guests were studied including bicyclic aliphatic
molecules (34-35), flexible aliphatic molecules (31, 33, 37), and aromatic molecules (32,
36, 38). Complexes of capsule 30:30 with guests 33, 35, and 36 in the gas phase were
studied by MS. The base peak corresponding to the capsule and one guest was seen for
all of the complexes. When 10% methanol was added to the complex, the mass peak for
28
the complex went away and a peak for the monomer was seen. Competition studies were
performed with all of the guests and studied by ESI. Figure 1-18 shows results of the
competition experiment with 33 being the best guest. Guests 31 and 32 were too big to be
encapsulated. This study further supports that size and shape are the most important
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Figure 1-18.  Tolylureacalix[4]arene and its Guest Molecules
A calix[4]arene derivative with tolylurea groups on the upper rim and decyl
groups on the lower rim  (40) was synthesized and studied for its ability to self-assemble
into a homodimer.27 Encapsulation studies were performed with the homodimer and
various guests in cyclohexane-d12. Guest escape from the complex was monitored by 
1H
NMR over time at room temperature. Rate constants and half-life's for the various guests
are listed in Table 1-4. Complexes with iodobenzene, p-xylene, trifluorotoluene, 1,4-
bis(trifluoromethyl)benzene, 1,4-dioxane and cyclohexanone were not soluble in
29
cyclohexane-d12. Toluene was seen to escape from the complex at a much faster rate than
benzene, but cyclohexane and methylcyclohexane have very similar half-life's that are 2
orders of magnitude higher then benzene's. Benzene and bromobenzene form complexes
of similar strength but changing from bromobenzene to chlorobenzene to fluorobenzene
to 1,4-difluorobenzene increases the half-life's from 23 h to 40 h to 74 h to 1470 h,
respectively. These studies show that by encapsulating an appropriate guest, the stability
of the dimer can be increased by several orders of magnitude.
Table 1-4.  Rate Constants for the Guest Escape (Exchange against C6D12) and Half-Life
Times of the Complexes of 40:guest:40
guest k, h-1 τ1/2, h
cyclohexane 3.68 x 10-4 1880
methylcyclohexane 3.89 x 10-4 1780
benzene 3.44 x 10-2 20
fluorobenzene 9.38 x 10-3 74
1,4-difluorobenzene 4.71 x 10-4 1470
chlorobenzene 1.74 x 10-2 40
bromobenzene 3.04 x 10-2 23
iodobenzene a




chloroform 2.36 x 10-1 2.9
tetrachloromethane 3.17 x 10-4 1120
1,4-dioxane a
cyclohexanone a
aComplex not soluble in cyclohexane. bCapsule is not soluble in an excess of the
guest.
1.3.2 Hydrogen Bonded Chiral Capsules
Chiral capsules were synthesized from calix[4]arene derivatives with phenyl ureas
substituted with aryl (39-40), sulfonylaryl (41), or chiral (42-52) groups on the upper rim
(Figure 1-19).28 These capsules were studied by 1H NMR for asymmetric binding of
30
several guests, such as (1R)-(+)-nopinone (53), (1R)-(-)-myrtenal (54), (1R)-(+)-camphor
(55), and tricyclene (56) in p-xylene-d10. Encapsulation of these guests in 39:39 reduces
the symmetry of the capsule in the 1H NMR because the top and bottom halves are no
longer magnetically equivalent. Compound 53 caused a doubling of the capsule
resonances when encapsulated. When symmetrical guest 56 is encapsulated, two different
sets of peaks for the guest are seen. These different sets of peaks correspond to capsules
with guests in different orientations. Unequal ratios in the peaks shows that there is a
preferred orientation and that the guest is not free to rotate inside the capsule. When 39
and 41 were mixed together, the heterodimer 39:41 was formed exclusively. The
heterodimer was found to be more stable than the homodimers 39:39 and 41:41 for two
reasons.29 The first reason is that the increased acidity of the sulfonylurea urea proton
complements the increased basicity of the aryl urea proton. The second reason is that
NOESY studies found that the aryl groups of both ureas are close together. The aryl-aryl
interactions help stabilize the heterodimer. When 41 was mixed with an alkylurea
derivative, only 10% heterodimerization was seen by 1H NMR. Encapsulation of 54
within heterodimer 39:41 gave two sets of resonances for the guest molecule. The
encapsulated guest must have two preferred orientations within the capsule. When 53 was
encapsulated in heterodimer 39:42 in p-xylene-d10, only one set of peaks was observed
indicating that the guest has one preferred orientation. Encapsulation of 53 in capsule
39:45 provided the diastereomer of 39:53:42 and gave a different set resonances for both
the capsule and the guest. Complex 39:(+)-nopinone:42 is equivalent to complex 39:(-)-
nopinone:45 by 1H NMR. Complexes of capsule 39:42 with each enantiomer of nopinone
gave signals that resembled the above diastereomeric complexes. This proved that
31
capsules 39:42 and 39:45 are diastereomers of each other. Each capsule contained




























































Figure 1-19.  Chiral Ureacalix[4]arene Derivatives and Guest Molecules
32
Calix[4]arene derivatives substituted with amino acid ureas (45-52) on the upper
rim (Figure 1-19) were synthesized and studied for their ability to form homodimers and
heterodimers with 40 or 41.30 These heterodimers were also studied for their ability to
encapsulate (R)-(+)-3-methylcyclopentanone and (S)-(+)-methylcyclopentanone. The
isoleucine (47) and valine (48) derivatives were the only derivatives found to form
homodimers. All of the derivatives formed heterodimers with the tolylurea derivative
(40) in both chloroform-d and benzene-d6 (Table 1-5) but did not form heterodimers with
the tolylsulfonylurea derivative (41). Changing the solvent from chloroform-d to
benzene-d6 increased the stability of the heterodimers formed. The valine and isoleucine
urea derivatives heterodimerize exclusively with 40 in benzene-d6. NOE experiments
showed that the β-branched amino acids have favorable contacts with the tolyl urea of the
calix[4]arene stabilizing the heterodimers over the homodimers. Most of the capsules
formed in only one of the two diastereomeric forms with the hydrogen bonds going either
clockwise or counterclockwise. Circular dichroism spectroscopy proved the one
handedness of the capsules. Molecular modeling of capsule 40:48 suggested that the CD
spectrum represents the coupling between the dipoles of the tolyl group of 40 and the
calix[4]arene rings of 48. This alignment of tolyl and calix[4]arene groups is only
possible when the ureas are rotated in the clockwise direction. Because the dimers have
hydrogen bonds going in one direction, encapsulation of enantiomers gives rise to two
different signals. When a racemic guest is encapsulated within heterodimer 40:41, which
is racemic with respect to its hydrogen bond orientation, four signals are seen, which
correspond to the two enantiomeric guests and the two different directions in hydrogen
bonds. When (R)-(+)-3-methylcyclopentanone is encapsulated in heterodimer 40:41, two
33
signals are seen, one for each hydrogen bond direction. When (R)-(+)-3-
methylcyclopentanone is encapsulated in capsule 40:47, only one signal is seen because
of the one handedness of the capsule.
Table 1-5.  Percentage of Heterodimer Formed upon Combination of Arylurea 40 and






isoleucine 90% b 100%
valine >90% b 100%




aUnless otherwise specified the percentages shown reflect formation of one of two
possible heterodimers. Percentages vary ±5%. b<5% non-specific aggregation. c6.4:1 ratio
of heterodimers. d1.9:1 ratio of heterodimers. eBroad spectrum. f3.4:1 ratio of
heterodimers.
Dr. De Mendoza’s research group synthesized calix[4]arene derivatives with
either four Leu-octylamides or four LLeu-DLeu-OMe dipeptides on the upper rim (Figure
1-20).31 Two possible dimer structures were surmised (Figure 1-20). The first dimer
structure 59 is formed when the ureas hydrogen bond to each other and the side chains
stick out away from the interface. The second structure 60 consists of the ureas hydrogen
bonding to the peptide amides forming a larger extended cavity. Calix[4]arene 57 did not
dimerize under any of the experimental conditions. The dipeptide derivative 58 dimerized
in methylene chloride-d2 and toluene-d8 with association constants of 20 M
-1 and 5100 M-
1, respectively. The capsule structure was determined be structure 59 with the ureas
hydrogen bonding and the side chains sticking out. The side chains were found to form
34
additional hydrogen bonds between the amide donors of one chain and the carbonyl of an

































































  Figure 1-20.  Chiral UreaCalix[4]arene Derivatives and Proposed Dimer Structures
35
1.3.3 Hydrogen Bonded Capsules with Higher Kinetic Stabilities
Hydrogen bonded capsules with higher kinetic stabilities have been synthesized
from calix[4]arene derivatives with ureas on the upper rim substituted with large bulky
groups (Figure 1-21).32 Homo and heterodimers of the derivatives were studied by 1H
NMR in benzene-d6 (Table 1-6).
Table 1-6.  Dimerization of Tetra-Ureas 61-65a
Compound 61 62 63 64 65
61 + 0b 50c 39c 78b
62 0b 0b 0b 0b 0
63 50c 0b + 31c 0b
64 39c 0b 31c + 95b
65 78b 0 0b 95b -
aFor each pair the formation of dimers is indicated by +. Additionally, the amount
of heterodimers present in a 1:1 mixture in benzene-d6 at a total concentration of c = 2.5
mM is reported in %. bPlus one homodimer and one unpaired monomer. cPlus two
homodimers.
Benzene was used because it is a good solvent and guest for the dimers. 64 and 65 were
found to form a heterodimer almost exclusively. The heterodimer 64:65 was favored over
a mixture containing one homodimer 64:64 and one monomer 65. The half-life of the
complex 61:65 with encapsulated benzene was determined to be ~130 minutes and ~60
hours for 64:65 with encapsulated benzene. When 64 and 65 were dissolved in toluene or
p-xylene, no heterodimer was formed only homodimer 64:64 and monomer 65. Benzene
seems to be a more favorable guest than either toluene or p-xylene and is able to promote
the formation of the more strained heterodimer 64:65 whereas the toluene and p-xylene
are not. Heterodimer 64:65 with encapsulated benzene was stable at 40 °C for 18 hours in
cyclohexane-d12 showing the increased kinetic stability. Molecular modeling of
homodimer 65:65 showed that the inner cavity is not big enough to hold a benzene
36
molecule.33 This inability to encapsulate benzene is the reason that 65 does not
homodimerize in benzene. To see if a smaller guest would induce homodimerization, 65
was refluxed in methylene chloride in the presence of tetramethylammonium iodide and
chloride. Both complexes were isolated and characterized by 1H NMR in chloroform-d.
When complex 65:Me4N
+:65 was dissolved in DMSO-d6, the complex degraded slowly
into its monomer and guest with a half-life of ~93 hours. The authors rationalize that
mechanical entanglement of the bulky side chains protects the urea hydrogen bonds from






























Figure 1-21.  Ureacalix[4]arene Derivatives with Bulky Substituents
38
Rigid calix[4]arene derivatives with two diethyleneglycol tethers on the lower rim
attached to adjacent phenol oxygens were synthesized.34 These derivatives were
substituted on the upper rim with tolyl, t-butyltrityl, or sulfonyltolyl ureas (Figure 1-22).
The rigid derivatives, 66a and 66b, were compared to their flexible counter parts 67a and
67b. Both of the rigid derivatives formed homodimers in chloroform-d.
Disproportionation experiments were performed between the rigid derivatives and
flexible derivative 67c in chloroform-d. Calix[4]arene 67a was previously seen to form a
heterodimer exclusively when mixed with 67c. No heterodimers were seen in any of the
mixtures of 67c with the rigid derivatives even after eight equivalents of 67c was added.
Homodimers of the rigid derivatives were tested to see how much DMSO could be
tolerated before the dimer dissociated into a 1:1 ratio of dimer to monomer. Homodimer
66a:66a required 8% DMSO by volume and 66b:66b required >18% DMSO. This is
more than four times the amount of DMSO tolerated by the flexible derivatives.
Homodimer 66b:66b was found to be ~500 times more stable than 66a:66a in
chloroform with 12% DMSO. Complexes of the rigid homodimers 66a:66a and 66b:66b
and the flexible homodimer 67b:67b with encapsulated benzene were dissolved in
benzene-d6 and monitored for the release of the encapsulated benzene. The half-life’s
were determined to be 82 s, 2460 s, and 550 s, respectively. Half-life times for the release
of cyclohexane in a similar experiment were found to be 245 hours for 66a:66a and 6.3
hours for 67a:67a. Overall the rigid derivatives were found to have increased stability
compared to their flexible counterparts with the bulky side chain derivatives being more

























Figure 1-22.  Rigid and Flexible Ureacalix[4]arene Derivatives with Bulky Substituents
Dr. Shuker’s group synthesized calix[4]arene derivative 68 which was propylated
on the lower rim and substituted on the upper rim with four C-linked alanines (Figure 1-
23).35 Alaninocalix[4]arene (68) was found to self-assemble into homodimers in a
solution of methanol-d4 with 4% D2O. The association constant for the derivative in the
methanol-d6/4% D2O solution was calculated to be 29,000 M
-1. Two possible models
were theorized for the dimerization (Figure 1-23). In the first model (69), the dimer is
held together by eight hydrogen bonds. In the second model (70), the dimer is held
together by sixteen hydrogen bonds making it more favorable than the first model. The
dimer 68:68 was studied by 1H NMR for its ability to bind various amino acids. Two
40
amino acids, arginine and lysine, caused dramatic shifts in the 1H NMR upon addition.
Mass spectroscopy of the arginine or lysine and homodimer mixture gave a peak that
corresponded to a 1:1 complex of 68 and either arginine or lysine. The amino acid caused



















Figure 1-23.  C-Linked Alaninocalix[4]arene and its Possible Dimer Structures
1.3.4 Ionic Bonded Capsules in Polar Solvents
Dr. Reinhoudt’s group synthesized several calix[4]arene derivatives that were





























Figure 1-24.  Ionic Calix[4]arene Derivatives
The amidinium derivatives were found to dimerize with the sulfonato derivative through
ionic interactions in methanol/water solutions with up to 40% water. The proton signals
for the amidinium propyl side chain of 71 were shifted upfield in the 1H NMR spectrum
of 71:75. This upfield shift must be caused by the encapsulation of one of the side chains
inside the cavity upon dimerization. The protons on the isopropyl side chain of derivative
72 were shifted upfield in the 1H NMR spectrum of 72:75. Similar to the propyl
derivative, one of the isopropyl side chains must fit inside the cavity upon dimerization
causing the upfield shift. The protons of the heptyl side chain of derivative 73 were not
shifted upfield in the 1H NMR spectrum of 73:75. The heptyl side chain must be too large
to fit inside the cavity upon dimerization. Association constants, enthalpy, and entropy
were calculated by isothermal calorimetry titration (Table 1-7).
42
Table 1-7.  Thermodynamic Parameters for the Formation of Assemblies 71-74 with 75
as Determined by ITCa
assembly Ka (M
-1) ∆H (kJ mol-1) ∆S (J K-1 mol-1)
71:75 (8.5 ± 1.4) x 106 14.1 ± 0.1 180 ± 2
71:75b (2.1 ± 0.5) x 105 11.6 ± 0.5 141 ± 3
72:75 (6.4 ± 1.7) x 106 13.7 ± 0.2 176 ± 2
73:75 (1.1 ± 0.1) x 106 17.9 ± 0.1 176 ± 1
74:75 (1.9 ± 0.3) x 106 33.3 ± 0.3 231 ± 2
aMeasured in MeOH/H2O (χwater = 0.4) at 298 K, background electrolyte: 1 x 10
-2
M Bu4NClO4. 
bBackground electrolyte: 1 x 10-2 M TMACl.
The positive enthalpy values result from the enthalpy needed to desolvate the charged
amidinium groups minus the enthalpy needed for the assembly. The positive entropy
values are caused by the release of highly ordered solvent molecules into the bulk media
during assembly. Dimer 71:75 was studied for its ability to bind tetramethylammonium
chloride, tetramethylammonium bromide, or tetrabutylammonium chloride in methanol-
d4. Addition of excess of tetramethylammonium bromide or chloride causes a downfield
shift in the protons of the propyl side chains. This is caused by the encapsulation of the
guest and the ejection of the propyl side chain from the cavity back into bulk solution.
When an excess of tetrabutylammonium chloride was added, no change was seen in the
1H NMR because the guest was too large to fit inside the cavity. No change in chemical
shift was observed for the guest protons when encapsulated because an excess of the
guest was used,  causing the 1H NMR signal to be the average of the free and
encapsulated guest signals. When one equivalent of tetramethylammonium chloride was
added to a solution of the dimer, a small shift was seen in the guest protons by 1H NMR.
Fitting the data to a 1:1 binding model gave an association constant of 170 M-1 for the
guest encapsulation in methanol-d4. Acethylcholine, a neurotransmitter, and N-
43
methylquinuclidinium were also studied for encapsulation. Addition of excess
acethylcholine also caused a downfield shift in the protons from the propyl side chain.
When one equivalent of acethylcholine or N-methylquinuclidinium was added, an upfield
shift for the guest protons was observed. Using a 1:1 binding model, an association
constant of 37 M-1 and 24 M-1 was calculated for the binding of acethylcholine and N-
methylquinuclidinium respectively.
Ionic calix[4]arene derivatives with butyl groups on the lower rim and either four
amines, aminomethyls, carboxyls, phosphonates, phosphonatomethyls, or pyrazolyls on
the upper rim were synthesized (Figure 1-25) and studied by 1H NMR dilution studies
and Job plots for their ability to form heterodimers in methanol.37, 38 Association constants
calculated for these heterodimers ranged from 2 x 103 and 7 x 105 M-1 (Table 1-8).
Table 1-8.  Binding Constants, Ka (M
-1), and Gibbs Free Energies of Association (kcal









pyrazolium 78d (4±0.1)x103 -4.8 no shifts - (2±0.6)x103 -4.4
ammonium 77 (4±0.4)x105 -7.5 (3±1.1)x104 -6.0 (7±2.5)x105 -7.8
anilinium 81 (7±1.0)x103 -5.2 (7±1.3)x103d,e -5.2 (1±0.5)x104f -5.4
aUnless stated otherwise. bErrors are standard deviations from the nonlinear
regressions. cIn kcal mol-1. dDetermined by dilution titration. eIn DMSO-d6. 
fIn
D2O/CD3OD (1:4).
The authors found that the strongest dimers were formed from the monomers with the
largest difference in pKa’s between the acidic and basic groups on the upper rims. The
aminomethyl derivative 77 (pKa ≅ 9) formed the strongest dimers with the two
phosphonate derivatives (76 and 80) (pKa ≅ 2). The least basic pyrazole derivative 78
44
(pKa ≅ 2.5) did not dimerize with the less acidic carboxy derivative 79 (pKa ≅ 5) and
formed weak hydrogen bonded dimers with the phosphonate derivatives. Encapsulation
of tetramethylammonium, phenylalanine, N-methylpyrazinium iodide and N-methylated
nicotinamide by the capsules was also studied by 1H NMR38. No guest encapsulation was
seen. When N-methylpyrazinium iodide or N-methylated nicotinamide was added to a
solution of the phosphonate derivative 80, a 1:1 complex was formed between the
calix[4]arene and the guest. The cationic anilinium derivative 81 was added to the
preformed phosphonate:guest complex but no capsule:guest complex was seen by 1H



























Figure 1-25.  Calix[4]arene Derivatives that Dimerize through Ionic Interactions
45
A water-soluble capsule has been synthesized and studied for its ability to
encapsulate guests in polar solvents.39 The heterodimer 82:83 is formed from two
calix[4]arene derivatives (Figure 1-26). The first derivative 82 is substituted on its upper
rim with an alanine linked through its N-terminus. The second derivative 83 is substituted
on its upper rim with a propylamidine moiety. Both derivatives have ethoxyethyl groups
on their lower rims. The monomers and capsule are completely soluble in H2O at pH 9.
Capsule formation can be monitored by the upfield shift of the propylamidine groups by
1H NMR. The upfield shift is caused by the encapsulation of one of the propyl groups
from the amidines upon dimerization. The association constant was calculated to be 3.3 x
104 M-1 by isothermal calorimetry measurements. Encapsulation was studied using N-
methylquinuclidinium cation as a guest. Addition of 30 equivalents of the guest to the
capsule resulted in a downfield shift in the propylamidine groups caused by the ejection
















Figure 1-26.  Water-Soluble Ionic Calix[4]arene Derivatives
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1.4 Conclusion
Molecular capsules can be formed from many different molecules. Two of these
molecules are cavitands and calix[4]arenes. Cavitands form capsules through the covalent
bonding of two cavitands rim to rim. These capsules are called carcerands and
hemicarcerands.  Carcerands encapsulate guest molecules irreversibly upon formation.
Hemicarcerands encapsulate guest molecules reversibly. Guests can enter and exit the
capsule at elevated temperatures but cannot enter or exit the capsule at room temperature.
Calix[4]arene derivatives form noncovalent capsules that are held together with hydrogen
or ionic bonding. These capsules encapsulate guests reversibly in both nonpolar and polar
solvents. In order to be used in biological applications, the capsules must be water-
soluble. There are only a few examples of water-soluble capsules in literature to date.
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Molecular recognition is a fast and growing field. It is the synthesis and study of
molecules capable of recognizing and binding one another through intermolecular
interactions such as hydrogen bonds, π-stacking, hydrophobic interactions, electrostatic
interactions, and van der Waals interactions. These molecules can then be used as
receptors, transport agents, catalysts, biocatalysts, supramolecular arrays, and for drug
transport and delivery. Molecular recognition can be used to create self-assembling
capsules.1 A self-assembling capsule is a supramolecular structure made up of two or
more molecules that come together through noncovalent, reversible interactions to form
an enclosed cavity. If an appropriate guest molecule is mixed in with the monomers, the
guest will be encapsulated within the cavity.
To utilize the capsules for a broader range of applications, the capsules and
capsule-guest complexes must self-assemble and be soluble in polar, protic solvents and
nonpolar solvents. There are many examples of self-assembling molecular capsules in
literature that assemble through hydrogen bonding.2-12 Hydrogen bonds are formed from
electrostatic interactions between the dipole of a hydrogen donor (AH) and hydrogen
acceptor (B). The small size of the hydrogen atom allows the donor and acceptor to come
into close contact increasing the strength of the dipole-dipole interactions. Hydrogen
bonds vary in strength from 1 to 10 kcal/mol depending on the atoms in the donor and
acceptor groups.13, 14 Most of these capsules assemble in nonpolar solvents and the
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addition of even small amounts of polar solvents disrupts the self-assembly. This makes
them unsuitable for many applications. There are only a few know examples of hydrogen
bond mediated self-assembly in polar solvents.15-18
Ionic bonds are bonds formed through the electron transfer from a negatively
charged ion to a positively charged ion. The energy cost of the electron transfer is
overcome by the energy gained from the favorable electrostatic attraction between the
ions. The ionic bond formed between a carboxylate ion and an alkylammonium ion has a
Gibbs free energy of ~5 kJ/mol in water.19, 20 An amide-amide hydrogen bond has a Gibbs
free energy of ~5 kJ/mol in chloroform.20 Nonpolar solvents are known to greatly
increase the strength of noncovalent interactions such as ionic and hydrogen bonding.
The fact that the ionic bond has a similar strength in water to that of the hydrogen bond in
chlorform demonstrates the increased strength of ionic bonds over hydrogen bonds. Some
recent publications report the synthesis of molecular capsules that assemble through ionic
interactions in polar solvents.21-25 These monomers dimerize more readily in polar
solvents due to the increased bond strength of ionic bonds over hydrogen bonds.
Calix[4]arenes derivatives substituted with charged functionalities on the upper rim and
propyl groups on the lower rim were synthesized. These derivatives dimerize through
ionic interactions in polar solvents forming both heterodimers and homodimers. These
dimers will be used to encapsulate various guest molecules. Although the ionic
propoxycalix[4]arene monomers are water-soluble, the heterodimers are not. This is due
to the shielding of the charges upon assembly, leaving only the propyl groups on the
lower rim exposed to the polar solvent. To use calix[4]arene capsules for drug delivery
and other biological applications, the capsules must be water-soluble. Calix[4]arene
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derivatives are being synthesized with hydroxy ethyl groups instead of the propyl groups
on the lower rim. When the charged hydroxyethoxycalix[4]arene derivatives dimerize,
the alcohols will be exposed to the polar solvent increasing the water-solubility of the
capsules.
2.2 Calix[4]arene Heterodimers
Several calix[4]arene derivatives propylated on the lower rim and substituted on
the upper rim with various functional groups have been synthesized. Examples include C-
linked-alaninocalix[4]arene (84), N-linked-alaninocalix[4]arene (85), anilinocalix[4]arene
(86), carboxycalix[4]arene (87), carboxyphenylcalix[4]arene (88), amidinocalix[4]arene
(89), and aminomethylcalix[4]arene (90) (Figure 2-1). C-linked-alaninocalix[4]arene (84)
was synthesized by Dr. Beth Brewster.16 Carboxyphenylcalix[4]arene (88) was
synthesized and studied by Dr. Kevin Caran. These derivatives heterodimerize in polar
solvents. Figure 2-2 shows cartoons of the three different types of heterodimers studied: a
dimer assembled from two monomers without spacers (A), a dimer assembled from one
monomer without and one monomer with a spacer (B), and a dimer assembled from two
monomers that both contain spacers (C).
All of the dimers were studied by 1H NMR dilution studies in 95% dimethyl
sulfoxide-d6 (DMSO-d6) or 95% methanol-d4 (CD3OD) with 5% phosphate buffer. Along
with the dilution studies, the dimers were analyzed using Job Plots. A Job Plot is a graph
that plots the change in chemical shift multiplied by the mol fraction versus the mol
fraction. The 1H NMR spectra from both the Job Plots and the dilution studies have sharp
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peaks that are consistent with the formation of dimers and not larger assemblies, which




























Figure 2-1.  Calix[4]arene Heterodimer Derivatives
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= carboxylate groups = ammonium or amidinium groups




Figure 2-2.  Calix[4]arene Heterodimer Structures
2.2.1 Carboxycalix[4]arene
Carboxycalix[4]arene (87) was synthesized in six steps from t-butyl phenol (91)
(Scheme 2-1). t-Butyl calix[4]arene (92) was synthesized through a condensation reaction
of t-butyl phenol (91) and formaldehyde.26 The t-butyl groups were then removed using
aluminum chloride and phenol in toluene.26 Calix[4]arene (93) was then propylated using
iodopropane and sodium hydride in anhydrous dimethylformamide.27
Tetrapropoxycalix[4]arene (94) was brominated with N-bromosuccinamide in methylene
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chloride to form the bromo derivative 95. Bromocalix[4]arene (95) was converted into
nitrilocalix[4]arene (96) through the Rosenmund von Braun reaction.28 The nitrile was
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Scheme 2-1.  Synthesis of Carboxycalix[4]arene 87
The self-assembly of carboxycalix[4]arene (87) with C-linked-
alaninocalix[4]arene (84) or anilinocalix[4]arene (86) was studied by 1H NMR dilution
studies and Job Plots in DMSO-d6/5% aqueous phosphate buffer. 
1H NMR dilution
studies indicate that anilinocalix[4]arene (86) and carboxycalix[4]arene (87) do not
dimerize in the DMSO-d6/5% phosphate buffer at pH 4.3. The lack of assembly is shown
55
in the Job Plot of 86 and 87 (Figure 2-3) by the erratic points that do not have a



































Figure 2-3.  Job Plot of Carboxycalix[4]arene 87 and Anilinocalix[4]arene 86
Carboxycalix[4]arene (87) and C-linked-alaninocalix[4]arene (84) were found to
dimerize in DMSO-d6/5% phosphate buffer at pH 6.5. The association constant (Ka) of






A0[ ] + B0[ ] − C0[ ]( ) +
1
Kc ∂c −∂a( )
Equation 1
where [B0] = the initial concentration of monomer B, [A0] = the initial concentration of
monomer A, [C0] = the dimer concentration, ∂obs = the observed chemical shift, ∂a = the
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chemical shift of monomer A, ∂c = the chemical shift of the dimer, and Kc = the
association constant.
A graph of the change in chemical shift of the aromatic protons of C-linked-
alaninocalix[4]arene (84) versus concentration as a monomer and as a dimer with
carboxycalix[4]arene (87) is shown in Figure 2-4. The chemical shift of the aromatic
protons of the monomer alone does not change upon dilution. Upon dilution of the dimer,
the chemical shift increases towards that of the monomer. This indicates the presence of a
dimer at higher concentrations and the monomers at lower concentrations. The Job Plot
of 84 and 87 has a maximum at 0.5 that indicates the formation of a supramolecular
structure with a 1:1 ratio of the monomers (Figure 2-5). Anilinocalix[4]arene (86) did not
dimerize with carboxycalix[4]arene (87) due to the small difference in pKa between the
terminal amine of 86 (pKa ~4.7) and the acid of 87 (pKa ~4.2). Carboxycalix[4]arene (87,
pKa ~4.2) did dimerize with C-linked-alaninocalix[4]arene (84, pKa ~9) due to the larger






























Figure 2-4.  Change in Chemical Shift of the Aromatic Protons of C-Linked-































Figure 2-5.  Job Plot of Carboxycalix[4]arene 87 and C-Linked-Alaninocalix[4]arene 84
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2.2.2 N-Linked-alaninocalix[4]arene
N-linked-alaninocalix[4]arene (85) was synthesized in three steps from
carboxycalix[4]arene (87) (Scheme 2-2).  Carboxycalix[4]arene (87) was converted to the
acid fluoride 97 using diethylaminosulfur trifluoride (DAST) in methylene chloride.30 t-
Butyl protected alanine was then coupled to 97 using triethylamine in methylene chloride
to form t-butyl-protected alaninocalix[4]arene (98). Deprotection of 98 with































Scheme 2-2.  Synthesis of N-linked-Alaninocalix[4]arene 85
The self-assembly of N-linked-alaninocalix[4]arene (85) with C-linked-
alaninocalix[4]arene (84) or anilinocalix[4]arene (86) into heterodimers was studied by
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1H NMR in DMSO-d6/5% aqueous phosphate buffer. Anilinocalix[4]arene (86) did not
dimerize with N-linked-alaninocalix[4]arene (85) in DMSO-d6/5% phosphate buffer at
pH 4.3. The chemical shift of the beta protons of 85 from the monomer dilution study are
subtracted by the chemical shift of the beta protons of 85 from the dimer dilution study
and plotted versus concentration (Figure 2-6) to show the lack of dimerization. This plot
shows an almost linear line near zero indicating that indicated that the chemical shift of
the alanine derivative’s beta protons is the same with or without the addition of
anilinocalix[4]arene (86). A Job Plot of N-linked-alaninocalix[4]arene (85) and
anilinocalix[4]arene (86) is shown in Figure 2-7. The lack of assembly is shown in the






























Figure 2-6. Subtraction of the Chemical Shift of the Beta Protons from Dilution Studies
































Figure 2-7.  Job Plot of N-Linked-Alaninocalix[4]arene 85 and Anilinocalix[4]arene 86
N-linked-alaninocalix[4]arene (85) and C-linked-alaninocalix[4]arene (84) were
found to dimerize in DMSO-d6/5% phosphate buffer at pH 6.5. The association constant
(Ka) of dimer 84:85 was calculated to be  5040 M
-1 (Equation 1).29 Figure 2-8 is a plot of
the subtraction of the chemical shift of the beta protons of 85 alone from the chemical
shift of the beta protons of 85 from the dimer dilution study versus concentration. The
difference in chemical shifts decreases as the dimer is diluted indicating a shift from
dimer at higher concentrations to monomers at lower concentrations. Figure 2-9 is a
graph of the change in chemical shift of the aromatic protons of C-linked-
alaninocalix[4]arene (84) versus concentration as a monomer and as a dimer with N-
linked-alaninocalix[4]arene (85). The chemical shift, of the monomer aromatic protons,
does not change upon dilution. As the dimer is diluted, the chemical shift increases
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towards that of the monomer. This shift indicates the presence of a dimer at higher
concentrations and monomers at lower concentrations. The Job Plot of 84 and 85 has a
maximum at 0.5 that indicates the formation of a supramolecular structure with a 1:1
ratio of monomers (Figure 2-10). Anilinocalix[4]arene (86) did not dimerize with N-
linked-alaninocalix[4]arene (85) due to the small difference in pKa between it (pKa ~4.7)
and 85 (pKa ~2.4). N-linked-alaninocalix[4]arene (85, pKa ~2.4) did dimerize with C-






























Figure 2-8.  Subtraction of the Chemical Shift of the Beta Protons from Dilution Studies






























Figure 2-9.  Chemical Shift of the Aromatic Protons of C-Linked-Alaninocalix[4]arene




































Amidinocalix[4]arene (89) was synthesized from nitrilocalix[4]arene (96) in one
step using an alkylchloroaluminum amide (Scheme 2-3). The aluminum reagent was
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Scheme 2-3.  Synthesis of Amidinocalix[4]arene 89
No dimerization was observed in the dilution studies or Job Plots of
amidinocalix[4]arene (89) with carboxycalix[4]arene (87) in DMSO-d6/5% phosphate
buffer at pH 8.8. The lack of assembly is shown by graphing the chemical shifts of the
aromatic protons of 87 from the monomer dilution study are subtracted by the chemical
shift of the aromatic protons of 87 from the dimer dilution study versus concentration
(Figure 2-11). The plot of the subtracted chemical shifts stays around zero, which
indicates that the chemical shift of the acid derivative’s aromatic peaks is the same with
or without the addition of amidinocalix[4]arene (89). The lack of dimerization is also
shown in the erratic Job Plot that lacks a maximum (Figure 2-12). Dilution studies of
amidinocalix[4]arene (89) and N-linked-alaninocalix[4]arene (85) in CD3OD/5%
phosphate buffer at pH 8.8 are inconclusive. The Job Plot shows the formation of a dimer
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Figure 2-11.  Subtraction of the Chemical Shift of the Aromatic Protons from Dilution

































Figure 2-12.  Job Plot of Amidinocalix[4]arene 89 and Carboxycalix[4]arene 87
2.2.4 Aminomethylcalix[4]arene
Aminomethylcalix[4]arene (90) was synthesized from tetrapropoxycalix[4]arene
(94) in 5 steps (Scheme 2-4). Tetrapropoxycalix[4]arene (94) was formylated using 1,1-
dichlorodimethyl ether and titanium chloride.32 The tetraformylated derivative 99 was
then reduced with lithium aluminum hydride to hydroxymethylcalix[4]arene (100). The
hydroxy group was substituted with a chloride using thionyl chloride,33 which was then
displaced with an azide to form azidomethylcalix[4]arene (102). The azide was then
reduced with lithium aluminum hydride to afford the desired product,
aminomethylcalix[4]arene (90).34 Dimerization studies of aminomethylcalix[4]arene (90)
and N-linked alaninocalix[4]arene (85) were attempted in DMSO-d6 with 5% phosphate
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Scheme 2-4.  Synthesis of Aminomethylcalix[4]arene 90
2.2.5 Heterodimer Results
The ability of calix[4]arene derivatives to self-assemble into capsules in polar
solvents has been demonstrated. C-linked-alaninocalix[4]arene (84) dimerizes with N-
linked-alaninocalix[4]arene (85), carboxycalix[4]arene (87), and
carboxyphenylcalix[4]arene (88) in the DMSO-d6/5% phosphate buffer at pH 6.5 as
shown in Figure 2-13. The monomers with the largest pKa difference formed the strongest
dimer 84:85 (Ka = 5040 M
-1) followed by 84:88 (Ka = 4410 M
-1) and 84:87 (Ka = 1200 M
-
1). It is interesting to note that addition of the phenyl spacers to the calix[4]arene scaffold































Figure 2-13.  Comparison of the Dilution Studies of the Monomer 84 with all of the
Heterodimers Formed (84:85, 84:87, and 84:88)
2.3 Calix[4]arene Homodimers
Several calix[4]arene derivatives propylated on the lower rim and disubstituted
with ionic functional groups on the upper rim have been synthesized.  These derivatives
are dicarboxydiglycinocalix[4]arene (103), dialaninodicarboxycalix[4]arene (104), di-ß-
alaninodicarboxycalix[4]arene (105), and di-γ-aminobutyric acid dicarboxycalix[4]arene
(106) (Figure 2-14). Dialaninodicarboxycalix[4]arene (104) was synthesized and studied




























Figure 2-14.  Calix[4]arene Homodimer Derivatives
All of the derivatives were studied for their ability to self-assemble into
interdigitated homodimers by 1H NMR dilution studies. The dilution studies were
performed in 95% methanol-d4 (CD3OD) with 5% phosphate buffer (pH 6.5) or 5%
deuterium oxide (D2O). Figure 2-15 shows a cartoon of the dimerization. Job plots were
not performed because they are only used for supramolecular assemblies containing
heteromolecules. The 1H NMR spectra from the dilution studies have sharp peaks that are
consistent with the formation of small assemblies. Larger assemblies would have broader
peaks. The amino acids used were chosen to determine if the chain length would have
any effect on the association of the derivatives.
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= carboxylate groups = ammonium or amidinium groups
= phenyl or amino acid spacer
Figure 2-15.  Interdigitated Calix[4]arene Homodimer Structures
2.3.1 Dicarboxydiglycinocalix[4]arene
Dicarboxydiglycinocalix[4]arene (103) was synthesized from t-butyl phenol (91,
Scheme 2-1) in twelve steps (Scheme 2-5). Dihydroxydipropoxycalix[4]arene (107) was
synthesized from calix[4]arene (93, Scheme 2-1) using potassium carbonate and
iodopropane in acetonitrile.35, 36 Dihydroxydipropoxycalix[4]arene (107) was brominated
using bromine in methylene chloride to form dibromodihydroxydipropoxycalix[4]arene
(108). The dibromo derivative 108 is formed exclusively due to the increased reactivity
of the unsubstituted phenol rings over the alkylated phenol rings. The dibromo compound
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108 was then exhaustively propylated with iodopropane and sodium hydride in
anhydrous dimethyl formamide yielding dibromotetrapropoxycalix[4]arene (109). The
bromines were converted into nitriles using the Rosenmund Von Braun reaction.28
Dinitrilocalix[4]arene (110) was then hydrolyzed to dicarboxycalix[4]arene (111) using
potassium hydroxide in ethanol/water. The diacid was nitrated using 90% nitric acid and
glacial acetic acid in methanol to give dicarboxydinitrocalix[4]arene (112).27 The acids
were then converted into methyl esters using sulfuric acid in methanol. The nitro groups
were then reduced with Raney-nickel and hydrazine monohydrate in methanol to afford
dianilinodicarboxymethylcalix[4]arene (114).27 N-(9-Fluorenylmethoxycarbonyl (Fmoc)
protected glycine acid fluoride was coupled to 114 in methylene chloride. Deprotection
of the methyl ester and Fmoc carbamate was achieved in one step using sodium
hydroxide in a mixture of tetrahydrofuran, methanol, and water yielding the final product
dicarboxydiglycinocalix[4]arene (103).
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Scheme 2-5.  Synthesis of Dicarboxydiglycinocalix[4]arene 103
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Proton NMR dilution studies were performed with
dicarboxydiglycinocalix[4]arene (103) in 95% CD3OD with either 5% phosphate buffer
(pH 6.5) or 5% D2O. Figure 2-16 shows the chemical shift of the aromatic protons of 103
versus the concentration. In CD3OD with 5% phosphate buffer, the dilution curve is S-
shaped. This S-shape represents the shift in equilibrium from a solution where the
derivatives are mostly associating into dimers (high concentration) to a solution where
the derivatives are predominately monomers (low concentration). The association
constant (Ka) for 103 in CD3OD with 5% phosphate buffer was calculated to be 497 M
-1
using Equation 2.37, 38
∂obs = ∂m + ∂d −∂m( )
1+ 8K A0[ ] −1
1+ 8K A0[ ] +1
Equation 2
where ∂obs = the observed chemical shift, ∂m = the chemical shift of the monomer, ∂d = the
chemical shift of the dimer,  K = the association constant, and [A0] = the initial
concentration.
In CD3OD with 5% D2O, the curve starts out at ~7.2 ppm and starts to increase
rapidly towards the chemical shift of the monomer (~7.75 ppm). The steep slope and the
fact that the complexes never dissociates fully into monomers suggests that 103 forms
very strong complexes in CD3OD with 5% D2O. The data from the dilution study of 103
in CD3OD with 5% D2O does not fit the equation for the determination of the association
constant of a homodimer. While dicarboxydiglycinocalix[4]arene (103) is forming some
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Figure 2-16.  Dilution Study of Dicarboxydiglycinocalix[4]arene 103 in CD3OD with 5%
Phosphate Buffer or 5% D2O
2.3.2 Di-β-alaninodicarboxycalix[4]arene
Di-β-alaninodicarboxycalix[4]arene (105) was synthesized from
dianilinodicarboxymethylcalix[4]arene (114) (Scheme 2-6).  Fmoc protected β-alanine
acid fluoride was coupled to the calix[4]arene in methylene chloride. Deprotection of the
methyl ester and Fmoc carbamate was achieved in one step using sodium hydroxide in a
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Scheme 2-6.  Synthesis of Di-β-alaninodicarboxycalix[4]arene 105
Proton NMR dilution studies were performed with di-β-
alaninodicarboxycalix[4]arene (105) in 95% CD3OD with either 5% phosphate buffer
(pH 6.5) or 5% D2O (Figure 2-17). The results of the dilution studies were very similar to
the dilution studies of dicarboxydiglycinocalix[4]arene (103). In CD3OD with 5%
phosphate buffer, the dilution gave an S-shaped curve representing the shift in
equilibrium from dimers (higher concentrations) to predominately monomers (lower
concentrations). The association constant (Ka) for 105 in CD3OD with 5% phosphate
buffer was calculated to be 430 M-1 (Equation 2).37, 38 In CD3OD with 5% D2O, the curve
starts out at ~7.2 ppm and starts to increase rapidly towards the chemical shift of the
monomer (~7.75 ppm). The fact that the complex never dissociates fully into monomers
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along with the steep slope suggest that 105 forms stronger complexes in CD3OD with 5%
D2O than in CD3OD with 5% phosphate bufer. The data from the dilution study of 105 in
CD3OD with 5% D2O does not fit the equation for the determination of the association


























Figure 2-17.  Dilution Study of Di-β-alaninodicarboxycalix[4]arene 105 in CD3OD with
5% Phosphate Buffer or 5% D2O
2.3.3 Di-γ-aminobutyric acid dicarboxycalix[4]arene
Di-γ-aminobutyric acid dicarboxycalix[4]arene (106) was synthesized from
dianilinodicarboxymethylcalix[4]arene (114) (Scheme 2-7).  Fmoc protected γ-
aminobutyric acid fluoride was coupled to the calix[4]arene in methylene chloride.
Deprotection of the methyl ester and Fmoc carbamate was achieved in one step using
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sodium hydroxide in a mixture of tetrahydrofuran, methanol, and water yielding the final




















Scheme 2-7.  Synthesis of Di-γ-aminobutyric Acid Dicarboxycalix[4]arene 106
Figure 2-18 shows the chemical shift of the aromatic protons of di-γ-aminobutyric
acid dicarboxycalix[4]arene (106) versus the concentration from the 1H NMR dilution
studies in CD3OD with either 5% phosphate buffer (pH 6.5) or 5% D2O. The results of
the dilution studies were very similar to the dilution studies of
dicarboxydiglycinocalix[4]arene (103) and di-β-alaninodicarboxycalix[4]arene (105). In
CD3OD with 5% phosphate buffer, the dilution gave an S-shaped curve representing the
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shift in equilibrium from dimers (higher concentrations) to predominately monomers
(lower concentrations). The association constant (Ka) for 106 in CD3OD with 5%
phosphate buffer was calculated to be 180 M-1 (Equation 2).37, 38 In CD3OD with 5% D2O,
the curve starts out at ~7.25 ppm where the derivatives are mostly complexes and starts to
increase rapidly towards the chemical shift of the monomer (~7.7 ppm). The formation of
strong aggregates by 106 in CD3OD with 5% D2O is suggested by the steep slope of the
graph. The data from the dilution study of 106 in CD3OD with 5% D2O does not fit the
equation for the determination of the association constant of a homodimer. The nature of
the aggregates formed from di-γ-aminobutyric acid dicarboxycalix[4]arene (106) in

























Figure 2-18. Dilution Study of Di-γ-aminobutyric Acid Dicarboxycalix[4]arene
106 in CD3OD with 5% Phosphate Buffer or 5% D2O
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2.3.4 Interdigitated Homodimer Results
All of the calix[4]arene derivatives were studied by 1H NMR for their ability to
form interdigitated homodimers in methanol-d4/5% D2O and methanol-d4/5% aqueous
phosphate buffer at pH 6.5.  All of the derivatives have similar association curves upon
dilution. The strongest dimer in the CD3OD with 5% phosphate buffer solution is the
alanine derivative 104 (Ka = 700 M
-1), which was synthesized and studied by Dr. Beth
Brewster. The second strongest dimer is the glycine derivative 103 Ka = (497 M
-1),
followed by the β-alanine derivative 105 (Ka = 430 M
-1), and the γ-aminobutyric acid
derivative 106 (Ka = 180 M
-1) (Figure 2-19). Increasing the chain length of the amino acid
weaked the binding strength of the dimer in the CD3OD/phosphate buffer solution. This
weakening of the association strength might be due to the increased flexibility of the
longer chains.
In the CD3OD with 5% D2O solution, di-β-alaninodicarboxycalix[4]arene (105)
forms the strongest complex followed closely by di-γ-aminobutyric acid
dicarboxycalix[4]arene (106),  diglycinodicarboxycalix[4]arene (103), and last
dialaninodicarboxycalix[4]arene (104) (Figure 2-20). While the derivatives do associate
into complexes in 95% deuterated methanol with 5% deuterium oxide, they do not form
dimers. The true nature of the complexes is still not fully understood. The chain length of
the amino acid does not seem to have an affect in the association of the derivatives in the
CD3OD/D2O solution suggested that the derivatives are associating in a different way




























Figure 2-19.  Dilution Studies of Interdigitated Homodimers in CD3OD with 5%
Phosphate Buffer (Ala = dialaninodicarboxycalix[4]arene 104; B-Ala = di-β-
alaninodicarboxycalix[4]arene 105; GABA = di-γ-aminobutyric acid




























Figure 2-20.  Dilution Studies of Interdigitated Homodimers in CD3OD with 5% D2O
(Ala = dialaninodicarboxycalix[4]arene 104; B-Ala = di-β-alaninodicarboxycalix[4]arene
105; GABA = di-γ-aminobutyric acid dicarboxycalix[4]arene 106; Gly =
dicarboxydiglycinocalix[4]arene 103)
2.4 Water-Soluble Calix[4]arene Derivatives
In order for calix[4]arene capsules to be used for drug delivery and other
biological applications, the capsules must be water-soluble. Although the
propoxycalix[4]arene derivatives contain ionic groups on their upper rims, the capsules
are not water-soluble. This is due to the shielding of the charges upon assembly leaving
only the hydrophobic propyl groups on the lower rim exposed to the polar solvent.
Calix[4]arene derivatives are being synthesized with hydroxy ethyl groups instead of the
propyl groups on the lower rim and. The hydroxyethoxycalix[4]arene derivatives will
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dimerize into homo- or heterodimers with the lower rim alcohols exposed to the polar















= carboxylate groups = ammonium or amidinium groups
= phenyl or amino acid spacer
BA
Figure 2-21. Water-Soluble Calix[4]arene Dimer Structures
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2.4.1 Towards the Synthesis of Water-Soluble Calix[4]arene Heterodimer
Derivatives
 The synthesis of water-soluble calix[4]arene heterodimers (A, Figure 2-21) has
been attempted through several different synthetic schemes. The first target was
anilinohydroxyethoxycalix[4]arene (118) which would then be used to synthesize several
tetrasubstituted hydroxyethoxycalix[4]arene derivatives 119a-d and 120a-d (Figure 2-
22). The synthesis of t-butylethylacetoxycalix[4]arene (125, Scheme 2-9) was the first
step in the route to 118. After several different attempts (Table 2-1) at synthesizing the
ester unsuccessfully from t-butylcalix[4]arene (92, Scheme 2-9), a new target was
chosen.39 In the unsuccessful attempts, several different products were formed with





















Figure 2-22. Water-Soluble Calix[4]arene Heterodimer Derivatives
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Table 2-1. Attempted Synthesis of t-Butylethylacetoxycalix[4]arene (125, Scheme 2-9)
from t-Butylcalix[4]arene 92
Reagent Base Solvent Temperature Time
Ethyl Bromoacetate NaH DMF (anh) R.T. 24 hrs
Ethyl Bromoacetate K2CO3 Acetone Reflux 24 hrs
Ethyl Bromoacetate K2CO3 DMF (anh) 70 °C 24 hrs
Ethyl Bromoacetate Cs2CO3 DMF (anh) 70 °C 24 hrs
Ethyl Iodoacetate NaH DMF (anh) R.T. 24 hrs
Ethyl Iodoacetate K2CO3 Acetone Reflux 24 hrs
Ethyl Iodoacetate NaH THF (anh) 67 °C 24 hrs
 The new target was t-butyl(1,2-dihydroxypropoxy)calix[4]arene (122) (Scheme
2-8). t-Butylcalix[4]arene (92) was reacted with allyl iodide and sodium hydride in
anhydrous dimethyl formamide to form t-butylallylcalix[4]arene (121). Oxidation of 121
with potassium permangenate,40, 41 was attempted but no reaction occured. Oxidation was
also attempted with silver acetate/iodine/acetic acid,42 and m-chloroperoxybenzoic acid
(m-CPBA). While the double bond did react, mixtures containing several different
products were formed. Bromination of the double bond was also attempted but yielded a
mixture of unseparable products. t-Butylallylcalix[4]arene (121) was refluxed with
glycidol and triethylamine in ethanol but no reaction occured.43
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Scheme 2-8. Attempted Synthesis of t-Butyl(1,2-dihydroxypropoxy)calix[4]arene 122
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Do to the lack of success using t-butylallylcalix[4]arene (121), our focus shifted
back to the synthesis of the first target, anilinohydroxyethoxycalix[4]arene (118, Figure
2-22). Ethyl bromoacetate and potassium carbonate in refluxing acetonitrile were found
to convert t-butylcalix[4]arene (92) into the desired t-butylethylacetoxycalix[4]arene
(125) (Scheme 2-9). The ester derivative 125 was then nitrated with nitric acid and acetic
acid in methylene chloride. The reduction of the nitrohydroxyethoxycalix[4]arene (126)
with tin chloride dihydrate44 in dimethyl formamide and water was unsuccessful, no
reaction occured. When heated in methanol with Raney nickel and hydrazine,27 the nitro
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Scheme 2-9. Towards the Synthesis of Anilinoethylacetoxycalix[4]arene 118
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In order to avoid the reaction of hydrazine with the ester group, 125 was
hydrolyzed with potassium hydroxide in refluxing ethanol to yield t-butylcalix[4]arene
acetic acid (129) (Scheme 2-10). No reaction proceeded from the attempted nitration of
129 using nitric acid and acetic acid in methylene chloride. Nitration of t-
butylhydroxyethoxycalix[4]arene under the same conditions was attempted by Suazette

















Scheme 2-10. Towards the Synthesis of Anilinohydroxyethoxycalix[4]arene 118
By changing the orientation of the oxygen and carbonyl in the ester derivative, the
reaction of hydrazine with the ester would produce the desired product
anilinohydroxyethoxycalix[4]arene (118) (Scheme 2-11). Unfortunately, none of the
reactions of t-butylcalix[4]arene (92) or calix[4]arene (93, Scheme 2-1) with


































Scheme 2-11. Towards the Synthesis of Anilinohydroxyethoxycali[4]arene 118
Table 2-2. Attempted Synthesis of calix[4]arene-ethoxyacetate derivatives 132 or 133
from t-Butylcalix[4]arene 92 or calix[4]arene 93
S.M. Reagent Base Solvent Temperature Time
92 Bromoethylacetate K2CO3 CH3CN Reflux 24 hrs
93 Bromoethylacetate K2CO3 CH3CN Reflux 24 hrs
93 Bromoethylacetate K2CO3, KI CH3CN Reflux 24 hrs
93 Bromoethylacetate K2CO3 none 80 °C 24 hrs
93 Bromoethylacetate K2CO3, KI none 80 °C 24 hrs
S.M. = starting material
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2.4.2 Towards the Synthesis of Water-Soluble Calix[4]arene Homodimer Derivatives
The synthesis of water-soluble interdigitated calix[4]arene homodimers (B, Figure
2-21) is underway. The main target is dianilinodicarboxyhydroxyethoxycalix[4]arene
(134), which could then be used to synthesize ionic hydroxyethoxycalix[4]arene
derivatives 135a-d disubstituted with amino acids and carboxylic acids on the upper rim
(Figure 2-23). Using the knowledge gained from attempting to synthesize water-soluble
heterodimers, hydroxyethoxycalix[4]arene (136) was the first target in the route to 134.
Several attempts at synthesizing hydroxyethoxycalix[4]arene directly from calix[4]arene
(93) were unsuccessful (Scheme 2-12). Bromopropanol was not reactive enough to
successfully react with 93. Ethylacetoxycalix[4]arene (137) was synthesized by refluxing
93 with ethyl bromoacetate and potassium carbonate in acetonitrile. The ester was then
reduced with lithium aluminum hydride in tetrahydrofuran to form
hydroxyethoxycalix[4]arene (136).45 All attempts at nitrating 136 with nitric acid and

























   CH3CN
reflux, 24 hrs








OH 4 O 4
OH
Bromopropanol
     Na2CO3
    DMF
RT, 24 hrs
    DMF
RT, 24 hrs
Bromopropanol
  Na2CO3, NaI
LAH
   THF
RT, 2 hrs








Scheme 2-12. Towards the Synthesis of Dianilinodicarboxyhydroxyethoxycalix[4]arene
134
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Calix[4]arene-ethoxyacetate (139) was synthesized by treating
hydroxyethoxycalix[4]arene (136) with acetyl chloride and triethylamine in methylene
chloride (Scheme 2-13). The ester derivative 139 was nitrated using nitric acid and acetic
acid in methylene chloride to give dinitrocalix[4]arene-ethoxy acetate (140).46 Although
the nitration did work, it required difficult purification resulting in low yields. Attempts
at dibromination of 136 and 139 with bromine or N-bromosuccinamide in methylene
chloride only led to a mixture of brominated products.
Acetyl Chloride
        Et3N
  CH2Cl2
RT, 24 hrs




































R = H or Ac
141, 142
Scheme 2-13. Towards the Synthesis of Dianilinodicarboxyhydroxyethoxycalix[4]arene
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Due to the inability to disubstitute hydroxyethoxycalix[4]arene (136), a new
scheme, similar to the one for synthesizing dicarboxydiglycinocalix[4]arene (103,
Scheme 2-5), was adopted (Scheme 2-14). Calix[4]arene (93) was treated with 2.2
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equivalents of ethyl bromoacetate and 1.1 equivalents of potassium carbonate in refluxing
acetonitrile to yield diethylacetoxycalix[4]arene (143).47 As seen in Scheme 2-5, the
dibromo derivative 143 is formed exclusively due to the increased reactivity of the
unsubstituted phenol rings over the alkylated phenol rings. The disubsituted derivative
143 was dibrominated with N-bromosuccinamide in methylene chloride.
Dibromodiethylacetoxycalix[4]arene (144) was refluxed with 10 equivalents of ethyl
bromoacetate and 10 equivalents of sodium carbonate in acetonitrile to form
dibromoethylacetoxycalix[4]arene (145).47 The esters were reduced with methylsulfide-
borane complex in THF to form dibromohydroxyethoxycalix[4]arene (141).48 All
attempts at converting the bromides into nitriles have been unsuccessful thus far. After
the nitrile derivative is synthesized, it will be hydrolyzed with potassium hydroxide to the
acid derivative 147. The acid derivative 147 will be nitrated and the nitro groups reduced
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Scheme 2-14. Towards the Synthesis of Dianilinodicarboxyhydroxyethoxycalix[4]arene
134
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2.4.3 Water-Soluble Calix[4]arene Derivative Results
The synthesis of water-soluble calix[4]arene heterodimers is well underway.
Several different routes to anilinohydroxyethoxycalix[4]arene (118) were attempted with
some success. Nitroethylacetoxycalix[4]arene (126) was synthesized but the reduction of
the nitro groups to form the aniline derivative 118 resulted in the formation of the
undesired byproduct 128 (Scheme 2-9). A new proposed route to the synthesis of
anilinohydroxyethoxycalix[4]arene (118), using some of the knowledge gained from the
homodimer derivative synthesis, is seen in Scheme 2-15. Reduction of t-
Butylethylacetoxycalix[4]arene (125) with lithium aluminum hydride will form the
alcohol derivative 149, which will be acylated with acetyl chloride to form t-
butylcalix[4]arene-ethoxyacetate (150). Acetate 150 will be nitrated and then reduced
with Raney nickel to form the desired product anilinohydroxyethoxycalix[4]arene (118).
The synthesis of water-soluble calix[4]arene homodimers is also underway.
Several different routes to dianilinodicarboxyhydroxyethoxycalix[4]arene (134) were
attempted with some success. Dibromohydroxyethoxycalix[4]arene (141) has been
synthesized and more work needs to be done in order to convert the bromides into nitriles
(Scheme 2-14).  If it is not possible to complete this transformation, the bromides may be
directly converted into carboxylic acids with lithium aluminum hydride and carbon
dioxide (Scheme 2-16).25 The acid derivative 147 could be nitrated and the nitro groups
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Scheme 2-16. New Route to the Synthesis of
Dianilinodicarboxyhydroxyethoxycalix[4]arene 134
2.5 Calix[4]arene Dimer Conclusions
The ability of calix[4]arene derivatives to self-assemble in polar solvents has been
demonstrated. C-linked-alaninocalix[4]arene (84) dimerizes with N-linked-
alaninocalix[4]arene (85), carboxycalix[4]arene (87), and carboxyphenylcalix[4]arene
(88) in the DMSO-d6/5% phosphate buffer at pH 6.5 as shown in Figure 2-13. The
monomers with the largest pKa difference formed the strongest dimer 84:85 (Ka = 5040
M-1) followed by 84:88 (Ka = 4410 M
-1) and 84:87 (Ka = 1200 M
-1). It is interesting to
note that addition of the phenyl spacers to the calix[4]arene scaffold increases the size of
the capsule with little effect on its ability to dimerize.
All of the interdigitated calix[4]arene derivatives have similar association curves
upon dilution. Dialaninodicarboxycalix[4]arene (104, Ka = 700 M
-1) formed the strongest
dimer in CD3OD with 5% phosphate buffer (pH 6.5) followed by diglycinodicarboxy-
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calix[4]arene (103, Ka = 497 M
-1), di-β-alaninodicarboxycalix[4]arene (105, Ka = 430 M
-
1), and last di-GABA-dicarboxycalix[4]arene (106, Ka = 180 M
-1) (Figure 2-19). The
chain length of the amino acid does have an affect on the binding affinity in the
CD4OD/buffer solution.  The longer chain lengths cause a decrease in the association
strength of the dimer. The incresed flexibility of the longer chains might weaken the
association strength of the dimer. In CD3OD with 5% D2O, the β-alanine derivative 105
forms the strongest complex followed closely by the GABA derivative 106, glycine
derivative 103, and the alanine derivative 104 (Figure 2-20). While the derivatives do
associate into complexes in 95% deuterated methanol with 5% D2O, they do not form
dimers. The true nature of the complexes is still not fully understood. The chain length of
the amino acid does not seem to have an affect in the association of the derivatives in the
CD3OD/D2O solution suggested that the derivatives are associating in a different way
than the dimers formed in the CD3OD/phosphate buffer solution.
The synthesis of water-soluble calix[4]arene heterodimers is well underway,
several different routes to anilinohydroxyethoxycalix[4]arene (118) have been attempted.
Nitroethylacetoxycalix[4]arene (126) was synthesized but the reaction to reduce the nitro
groups to form the aniline derivative 118 ended up reacting with the ester also (Scheme
2-9). A new route to the synthesis of anilinohydroxyethoxycalix[4]arene (118) is shown
in Scheme 2-15. The synthesis of water-soluble homodimers is also underway, several
different routes to dianilinodicarboxyhydroxyethoxycalix[4]arene (134) have been
attempted. Dibromohydroxyethoxycalix[4]arene (141) has been synthesized and more
work needs to be done in order to synthesize dicarboxyhydroxyethoxycalix[4]arene (147)
(Schemes 2-14 and 2-15).
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EXPERIMENTAL AND SPECTRAL DATA
3.1 General Conditions
Concentration of solutions was accomplished using a Labconco rotary evaporator
with a Neuberger Laboport vacuum pump. This was followed by removal of residual
solvent under high vacuum. Unless otherwise stated, reagents and solvents were used as
received from the manufacturer without further purification. Anhydrous tetrahydrofuran
was distilled from sodium-benzophenone ketyl under positive pressure of argon.
Reactions were monitored by thin layer chromatography using 0.25 mm silica gel
60 plates impregnated with a 254 nm florescent indicator. Plates were visualized by UV
light and/or using anisaldehyde, iodine, or potassium permanganate as staining agents.
Column chromatography was performed using silica gel 60, 230–400 mesh as a
stationary phase.
Melting points were recorded on a MelTemp II apparatus and are uncorrected.
NMR spectra were recorded on a Varian-Gemini-400 magnetic resonance spectrometer.
Proton NMR spectra are recorded in parts per million (ppm) relative to the peak of CDCl3
(7.24 ppm), DMSO-d6 (2.49 ppm), or CD3OD (3.30 ppm). Carbon-13 spectra were
recorded relative to the central peak of the chloroform-d1 triplet (77.0 ppm), the DMSO-
d6 septet (39.7 ppm), or the methanol-d4 septet (49.0 ppm), and were recorded with
complete hetero-decoupling. High-resolution mass spectra were recorded at the Georgia
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Synthesis of t-Butylcalix[4]arene 921
p-t-Butylphenol 91 (5 g, 1 eq) was added to a 37% formaldehyde (1.15 eq)/water
solution in a three-neck round bottom flask. A 40% sodium hydroxide (0.036 eq)/water
solution was added to the flask. The reaction was stirred for 15 minutes and then heated
to 1200C under a steady flow of nitrogen. After 3 hours, all of the reagents were dissolved
forming a yellow, viscous solution. The reaction was cooled overnight and diphenyl ether
(50 mL) was added. The reaction was heated back up to 1200C and nitrogen was bubbled
through the solution for 2 hours to remove water. The reaction was then refluxed for 3
hours and cooled overnight. Ethyl acetate was added and a white precipitate formed. The
precipitate was removed by filtration and washed with ethyl acetate, acetic acid,
deionized water, and acetone. The solid was then recrystallized from toluene. Gleaming
white crystals were recovered (2.06 g, 38% yield). M.P. = 339-342 °C; 1H NMR (400
MHz CDCl3): δ 10.31 (s, 4 H), δ 7.03 (s, 8 H), δ 4.24 (d, 4 H, J = 13.2 Hz), δ 3.48 (d, 4
H, J = 12.8 Hz), δ 1.20 (s, 36 H); 13C NMR (400 MHz, CDCl3): δ 146.5, 144.2, 127.5,
125.8, 32.7, 31.5; HRMS (FAB) Calcd. for C44H56O4 (M













Synthesis of Calix[4]arene 931
t-Butylcalix[4]arene 92 (50g, 1 eq) and aluminum trichloride (5.2 eq) were placed
in a round bottom flask under nitrogen. Toluene (1 L) was added to the reaction and
stirred. Phenol (4.8 eq) was added and the reaction was stirred for 3 days at room
temperature. The reaction was then poured over dilute HCl (1.5 L, 0.2 M). The organic
layer was washed with deionized water and brine. The organic layer was then dried over
magnesium sulfate, filtered, and concentrated in vacuo until most of the toluene was
gone. The product was precipitated out with methanol. The white solid was removed by
filtration and washed with methanol (27 g, 83% yield). M.P. = 313.6-315.0 °C; 1H NMR
(400 MHz CDCl3): δ 10.18 (s, 4 H), δ 7.04 (s, 4 H), δ 6.72 (t, 4 H, J = 7.5 Hz), δ 4.26 (br
s, 4 H), δ 3.54 (br s, 4 H); 13C NMR (400 MHz, CDCl3): δ 148.6, 128.8, 128.1, 122.1,
31.8; HRMS (FAB) Calcd. for C28H24O4 (M
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Synthesis of Tetrapropoxycalix[4]arene 942
Calix[4]arene 93 (100 mg, 1 eq) was dissolved in anhydrous DMF (2.5 mL) in a
round bottom flask under nitrogen. Sodium hydride (6 eq) was added and stirred for 30
minutes. Iodopropane (6 eq) was added and stirred at room temperature. The reaction was
monitored by TLC (5:1, hexane:EtOAc). After 4 hours, the reaction looked complete.
The reaction was extracted with methylene chloride and washed with saturated
ammonium chloride, deionized water, and brine. The organic layer was dried over
magnesium sulfate and concentrated in vacuo. The product was recovered as an off-white
solid (141 mg, >99%) and the structure was determined by NMR. M.P. = 199.3-200.0 °C;
1H NMR (400 MHz CDCl3): δ 6.61-6.55 (3, 12 H), δ 4.45 (d, 4 H, J = 13.2 Hz), δ 3.85 (t,
8 H, J = 7.5 Hz); δ 3.15 (d, 4 H, J = 13.6 Hz); δ 1.96-1.90 (m, 8 H); δ 1.00 (t, 12 H, J =
7.3 Hz); 13C NMR (400 MHz, CDCl3): δ 156.4, 135.0, 128.0, 121.7, 76.7, 31.1, 23.4,
10.5; HRMS (FAB) Calcd. for C40H48O4 (M
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Synthesis of Tetrabromotetrapropoxycalix[4]arene 95
Tetrapropoxycalix[4]arene 94 (50 mg, 1 eq) was dissolved in methylene chloride
(1 mL) in a round bottom flask under nitrogen. NBS (4.5 eq) was added and stirred at
room temperature. The reaction was monitored by TLC (5:1, hexane:EtOAc). The NBS
did not dissolve and no reaction was proceeding after 1 hour so methanol (0.5 mL) was
added and stirred overnight. After 24 hours, the solution turned from clear to brown and
the reaction looked complete. The reaction was washed with saturated sodium
bicarbonate and brine. The organic layer was dried over magnesium sulfate and
concentrated in vacuo. A tan solid was recovered (78 mg, >99%). M.P. = 179 °C (dec.);
1H NMR (400 MHz CDCl3): δ 6.78 (s, 8 H), δ 4.33 (d, 4 H, J = 13.6 Hz), δ 3.78 (t. 8 H, J
= 7.5 Hz), δ 3.06 (d, 4 H, J = 13.6 Hz), δ 1.85 (m, 8 H, J = 7.7 Hz), δ 0.95 (t, 12 H, J =
7.5 Hz); 13C NMR (400 MHz, CDCl3): δ 155.3, 136.3, 130.8, 115.0, 30.8, 23.2, 10.4;
HRMS (FAB) Calcd. for C40H44
79Br4O4 (M












Synthesis of Tetranitrilotetrapropoxycalix[4]arene 963
Tetrabromotetrapropoxycalix[4]arene 95 (50 mg, 1 eq) and copper cyanide (6 eq)
were dissolved in N-methylpyrrolidinone (2 mL) in a round bottom flask under nitrogen.
The reaction was refluxed overnight and turned from tan to a dark red/brown. The
reaction was cooled to 1000C and a solution of ferrous chloride hexahydrate (8 eq), HCl
(0.25 mL) and deionized water (1.25 mL) was added and stirred for 1 hour. The reaction
was then cooled to room temperature and filtered. The solid was washed with water and
left on the filter to dry. The solid was then dissolved in methylene chloride and purified
by column chromatography (CH2Cl2 then CH2Cl2:MeOH 99:1). The second fraction (1.6
g, 72%) was concentrated in vacuo. M.P. > 320 °C; 1H NMR (400 MHz CDCl3): δ 6.98
(s, 8 H), δ 4.42 (d, 4 H, J = 13.6 Hz), δ 3.88 (t. 8 H, J = 7.4 Hz), δ 3.23 (d, 4 H, J = 13.6
Hz), δ 1.87 (m, 8 H, J = 7.2 Hz), δ 0.98 (t, 12 H, J = 7.2 Hz); 13C NMR (400 MHz,
CDCl3): δ 160.0, 135.6, 132.4, 118.2, 106.8, 77.5, 30.5, 23.2, 10.1; HRMS (FAB) Calcd.
for C44H45N4O4 (M
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Synthesis of Tetracarboxytetrapropoxycalix[4]arene 87
Tetranitrilotetrapropoxycalix[4]arene 96 (500 mg, 1 eq) and ethanol (50 mL) were
placed in a round bottom flask. Potassium hydroxide (40.5 g, 1000 eq) was dissolved in
deionized water (50 mL) and added to the flask. The reaction was refluxed overnight. The
reaction was acidified with concentrated hydrochloric acid and the product precipitated
out. The precipitate (white solid, 503 mg, 91%) was removed by filtration and washed
with deionized water and diethyl ether. M.P. > 320 °C; 1H NMR (400 MHz DMSO-d6): δ
12.31 (s, 4 H), δ 7.31 (s, 8 H), δ 4.34 (d, 4 H, J = 12.8 Hz), δ 3.87 (t. 8 H, J = 6.4 Hz), δ
1.88 (m, 8 H, J = 7.0 Hz), δ 0.97 (t, 12 H, J = 6.8 Hz); 13C NMR (400 MHz, DMSO-d6):
δ 166.7, 159.8, 134.3, 129.6, 124.6, 76.7, 30.3, 23.1, 10.4; HRMS (FAB) Calcd. for
C44H48O12 (M
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Synthesis of Tetracarboxyfluorotetrapropoxycalix[4]arene 974
Tetracarboxytetrapropoxycalix[4]arene 87 (1.10 g, 1 e•) was dissolved in
methylene chloride (15 mL) in a round bottom flask under nitrogen.
Dimethylaminosulfur trifluoride (DAST, 2.30 mL, 12 eq) was added to the reaction. The
reaction was stirred at room temperature and monitored by TLC (9:1, CH2Cl2: MeOH).
After 3 hours, the reaction was quenched with ice-cold deionized water. The organic
layer was separated and washed with more deionized water. The organic layer was then
dried over magnesium sulfate and concentrated in vacuo. The crude product (tan solid,
1.1 g, 98%) was used without further purification. 1H NMR (400 MHz CDCl3): δ 7.33 (s,
8 H), δ 4.48 (d, 4 H, J = 14.0 Hz), δ 3.94 (t. 8 H, J = 7.4 Hz), δ 3.33 (d, 4 H, J = 14.0
Hz), δ 1.90 (m, 8 H, J = 7.6 Hz), δ 1.01 (t, 12 H, J = 7.4 Hz); 13C NMR (400 MHz,
CDCl3): δ 162.3, 158.2, 154.8, 135.4, 131.9, 119.4, 118.8, 77.4, 30.9, 23.4, 10.3; HRMS
(EI) Calcd. for C44H44F4O8 (M















Synthesis of Tetra-t-butylalaninotetrapropoxycalix[4]arene 98
t-Butyl-alanine hydrochloride (704 mg, 12 eq) was dissolved in methylene
chloride (4 mL) in a round bottom flask under nitrogen. Triethylamine (0.5 mL, 12 eq)
was added to the reaction and stirred. Tetracarboxyfluoro-tetrapropoxycalix[4]arene 97
(250 mg, 1 eq) was then added to the reaction. The reaction was stirred at room
temperature and monitored by TLC (1:1, hexane:EtOAc). After 1 hour, the reaction was
washed with saturated ammonium chloride and then brine. The organic layer was dried
over magnesium sulfate and concentrated in vacuo. The product was purified by column
chromatography (CH2Cl2 then 99:1, CH2Cl2: MeOH) yielding a yellow, fluffy solid (273
mg, 66%). M.P. = 118 °C (dec.); 1H NMR (400 MHz CDCl3): δ 7.18 (s, 4 H), δ 7.00 (s, 4
H), δ 4.43 (m, 8 H), δ 3.85 (t. 8 H, J = 7.5 Hz), δ 3.23 (d, 4 H, J = 13.6 Hz), δ 1.88 (m, 8
H, J = 7.7 Hz), δ 1.44 (m, 48 H), δ 0.97 (t, 12 H, J = 7.3 Hz); 13C NMR (400 MHz,
CDCl3): δ 172.2, 166.6, 159.0, 134.7, 134.4, 128.3, 128.0, 126.6, 81.5, 77.0, 49.2, 31.1,
28.1, 23.2, 18.4, 10.4; HRMS (FAB) Calcd. for C72H101N4O16 (M
+1): m/z = 1277.72126

















Synthesis of Tetra-alaninotetrapropoxycalix[4]arene 85
Tetra-t-butylalaninotetrapropoxycalix[4]arene 98 (30 mg, 1 eq) was dissolved in
methylene chloride (0.95 mL) in a round bottom flask under nitrogen. Trifluoroacetic
acid (0.05 mL) was added to the reaction. The reaction was stirred at room temperature
and monitored by TLC (1:1, hexane:EtOAc). After 2 hours, the solvent was removed in
vacuo yielding a fine, white solid (30 mg, >99%). M.P. = 218 °C (dec.); 1H NMR (400
MHz DMSO-d6): δ 8.19 (d, 4 H, J = 6.8 Hz), δ 7.36 (s, 4 H), δ 7.39 (s, 4 H), δ 4.42 (d, 4
H, 12.8 Hz), δ 4.24 (m, 4 H, J = 7.0 Hz), δ 3.89 (t. 8 H, J = 7.6 Hz), δ 1.92 (m, 8 H, J =
7.6 Hz), δ 1.32 (d, 12 H, J = 6.8 Hz), δ 0.98 (t, 12 H, J = 7.6 Hz); 13C NMR (400 MHz,
DMSO-d6): δ 174.6, 166.1, 158.7, 134.2, 134.0, 128.5, 128.4, 127.9, 76.8, 48.4, 30.7,
22.9, 17.0,10.4; HRMS (FAB) Calcd. for C56H69N4O16 (M
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Synthesis of Tetra-amidinotetrapropoxycalix[4]arene 895
Ammonium chloride (306 mg, 40 eq) was dissolved in dichloroethane (4 mL) in a
round bottom flask under nitrogen. The reaction was cooled to 0 oC and trimethyl
aluminum (2 M, 2.9 mL, 40 eq) was added dropwise. When the bubbling stopped (~2
hours), tetranitrilocalix[4]arene 96 (100 mg, 1 eq) dissolved in dichloroethane (2 mL)
was added to the reaction. The reaction was warmed to room temperature and the
refluxed for 11 days. The reaction was then cooled to 0 oC and quenched with ice (10 g)
and methanol (15 mL). The solution was filtered over celite and the solid was washed
with methanol and deionized water. The combined filtrates were concentrated in vacuo.
Hydrochloric acid (3 N, 40 mL) was added and some of the solid dissolved. The
remaining solid was removed by filtration and the filtrate was concentrated in vacuo.
NMR of the solid showed that it was product (96 mg, 73%). M.P. > 320 °C; 1H NMR
(400 MHz DMSO-d6): δ 9.29 (s, 6 H), δ 8.85 (s, 6 H), δ 7.59 (s, 8 H), δ 4.40 (d, 4 H, 13.2
Hz), δ 3.91 (t, 8 H, J = 7.6 Hz), δ 3.39 (d. 4 H, J = 13.6 Hz), δ 1.88 (m, 8 H, J = 7.2 Hz),
δ 0.97 (t, 12 H, J = 7.2 Hz); 13C NMR (400 MHz, DMSO-d6): δ 164.0, 160.5, 134.7,
129.1, 121.1, 76.9, 30.2, 22.8, 10.1; HRMS (FAB) Calcd. for C44H57N8O4 (M
+1): m/z =
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Synthesis of Tetraformyltetrapropoxycalix[4]arene 996
1,1-Dichlorodimethylether (0.11 mL, 14 eq) and titanium chloride (0.15 mL, 16
eq) were dissolved in chloroform (3 mL) in a round bottom flask under nitrogen. The
reaction was cooled to 0 oC and tetrapropoxycalix[4]arene  94 (50 mg, 1 eq) was added
dropwise to the solution. The reaction was stirred for 1 hour and then warmed to room
temperature and stirred overnight. The reaction was then quenched with deionized water.
The organic layer was separated and washed with more deionized water. The organic
layer was then dried over magnesium sulfate and concentrated in vacuo. The product (31
mg, 52%) was purified by column chromatography (8:2, hexane:EtOAc). M.P. 270-274
°C; 1H NMR (400 MHz CDCl3): δ 9.56 (s, 4 H), δ 7.13 (s, 8 H), δ 4.49 (d, 4 H, J = 13.6
Hz), δ 3.92 (t. 8 H, J = 7.4 Hz), δ 3.34 (d, 4 H, J = 14.0 Hz), δ 1.90 (m, 8 H, J = 7.6 Hz),
δ 1.01 (t, 12 H, J = 7.6 Hz); 13C NMR (400 MHz, CDCl3): δ 191.0, 161.7, 135.4, 131.2,
130.1, 77.2, 31.0, 23.4, 10.4; HRMS (FAB) Calcd. for C44H49O8 (M
+1): m/z = 705.34274
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Synthesis of Tetrahydroxymethyltetrapropoxycalix[4]arene 100
Tetraformyltetrapropoxycalix[4]arene 99 (833 mg, 1 eq) was dissolved in
anhydrous THF (30 mL) in a round bottom flask under nitrogen. Lithium aluminum
hydride (540 mg, 12 eq) was added and stirred at room temperature overnight. The
reaction was then quenched with distilled water. The solution was then acidified with 1N
HCl and extracted with methylene chloride. The organic layer was separated and washed
with deionized water and brine. The organic layer was then dried over magnesium sulfate
and concentrated in vacuo yielding hydroxymethylcalix[4]arene (685 mg, 81%). M.P.
250-253 °C; 1H NMR (400 MHz CDCl3): δ 6.66 (s, 8 H), δ 4.43 (d, 4 H, J = 13.2 Hz), δ
4.34 (s, 8 H), δ 3.83 (t. 8 H, J = 7.4 Hz), δ 3.14 (d, 4 H, J = 13.2 Hz), δ 1.93 (m, 8 H, J =
7.2 Hz), δ 0.99 (t, 12 H, J = 7.4 Hz); 13C NMR (400 MHz, CDCl3): δ 155.8, 134.8, 134.4,
126.9, 76.9, 64.8, 31.1, 23.3, 10.4; HRMS (FAB) Calcd. for C44H56O8 (M
+): m/z =

















Synthesis of Tetra-azidotetrapropoxycalix[4]arene 1027
Tetrahydroxymethyltetrapropoxycalix[4]arene 100 (685 mg, 1 eq) was dissolved
in methylene chloride (20 mL) in a round bottom flask under nitrogen. Thionyl chloride
(1.4 mL, 20 eq) was added and stirred at room temperature for two hours. The reaction
was then concentrated in vacuo and redissolved in anhydrous DMF (20 mL). Sodium
azide (625 mg, 10 eq) was then added and stirred over the weekend at room temperature.
The reaction was then quenched with 1N HCl. The solution was then extracted with
methylene chloride. The organic layer was washed with deionized water until all of the
DMF was removed. The organic layer was then dried over magnesium sulfate and
concentrated in vacuo. The product was then purified through a silica plug yielding
azidomethylcalix[4]arene (200 mg, 26%). M.P. = 200-202 °C; 1H NMR (400 MHz
CDCl3): δ 6.59 (s, 8 H), δ 4.43 (d, 4 H, J = 13.2 Hz), δ 3.93 (s, 8 H), δ 3.83 (t. 8 H, J =
7.6 Hz), δ 3.14 (d, 4 H, J = 13.2 Hz), δ 1.91 (m, 8 H, J = 7.6 Hz), δ 0.98 (t, 12 H, J = 8.0
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Synthesis of Tetra-aminomethyltetrapropoxycalix[4]arene 908
Azidomethyltetrapropoxycalix[4]arene 102 (50 mg, 1 eq) was dissolved in
anhydrous THF (4 mL) in a round bottom flask under nitrogen. Lithium aluminum
hydride (28 mg, 12 eq) was added and stirred overnight at room temperature. The
reaction was then quenched with distilled water and extracted with methylene chloride.
The organic layer was washed with deionized water and brine. An emulsion formed that
separated upon addition of KOH (5% in water). The organic layer was then dried over
magnesium sulfate and concentrated in vacuo yielding aminomethylcalix[4]arene (30 mg,
68%). The product was characterized by NMR. M.P. 240 °C (dec.); 1H NMR (400 MHz
CD3OD): δ 6.89 (s, 8 H), δ 4.48 (d, 4 H, J = 13.2 Hz), δ 3.87 (t. 8 H, J = 7.2 Hz), δ 3.83
(s, 8 H), δ 3.27 (d, 4 H, J = 13.2 Hz), δ 1.94 (m, 8 H, J = 7.2 Hz), δ 1.02 (t, 12 H, J = 7.2
Hz); 13C NMR (400 MHz, CD3OD): δ 158.4, 136.8, 130.6, 128.1, 78.2, 44.0, 31.7, 24.4,
10.8; HRMS (FAB) Calcd. for C44H61N4O4 (M
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Synthesis of Dipropoxycalix[4]arene 1079, 10
Calix[4]arene 93 (27 g, 1 eq) was placed in a round bottom flask with acetonitrile
(900 mL) under nitrogen. Potassium carbonate (2 eq) and iodopropane (4 eq) were added
to the reaction and refluxed. After 24 hours, the reaction was concentrated to dryness and
redissolved in methylene chloride and 1 N HCl. The organic layer was separated and
washed with 1 N HCl, deionized water, and brine. The organic layer was dried over
magnesium sulfate, filtered, and concentrated in vacuo. The product, a white solid, was
then recrystallized from methylene chloride and methanol (25 g, 78% yield). M.P. 260 °C
(dec.); 1H NMR (400 MHz CDCl3): δ 8.34 (s, 2 H), δ 7.06 (d, 4 H, J = 7.6 Hz), δ 6.92 (d,
4 H, J = 7.6 Hz), δ 6.74 (t, 2 H, J = 7.2 Hz), δ 6.65 (t, 2 H, J = 7.2 Hz), δ 4.33 (d, 4 H, J =
12.8 Hz), δ 3.98 (t, 4 H, J = 6.0 Hz), δ 3.38 (d, 4 H, J = 12.8 Hz), δ 2.09-2.06 (m, 4 H), δ
1.32 (t, 6 Hz, J = 7.6 Hz); 13C NMR (400 MHz, CDCl3): δ 153.3, 151.8, 133.5, 128.9,
128.4, 128.1, 125.3, 118.9, 78.3, 31.4, 23.5, 10.9; HRMS (FAB) Calcd. for C34H36O4
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Synthesis of Dibromodipropoxycalix[4]arene 108
Dipropoxycalix[4]arene 107 (4.7 g, 1 eq) was dissolved in methylene chloride (1
L) in a round bottom flask under nitrogen. Bromine (3 eq) was added and stirred. The
product precipitates upon formation. After 3 hours, the product, a white solid, was
removed by filtration and washed with methylene chloride (5.8 g, 95% yield). M.P. > 320
°C; 1H NMR (400 MHz CDCl3): δ 8.36 (s, 2 H), δ 7.15 (s, 4 H), δ 6.92 (d, 4 H, J = 7.2
Hz), δ 6.79 (t, 2 H, J = 7.2 Hz),  δ 4.23 (d, 4 H, J = 12.8 Hz), δ 3.93 (t, 4 H, J = 6.0 Hz), δ
3.30 (d, 4 H, J = 14.0 Hz), δ 2.05-1.95 (m, 4 H), δ 1.27 (t, 6 Hz, J = 7.2 Hz); HRMS (EI)
Calcd. for C34H34Br2O4 (M
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Synthesis of Dibromotetrapropoxycalix[4]arene 109
Dibromodipropoxycalix[4]arene 108 (5.8 g, 1 eq) was dissolved in anhydrous
DMF in a round bottom flask under nitrogen. Sodium hydride (4 eq) was added to the
reaction and stirred for 30 minutes. Iodopropane (6 eq) was added and the reaction was
heated to 50 °C and stirred overnight. The reaction was monitored by TLC (5:1,
hexane:EtOAc). The reaction was quenched with deionized water and 1 N HCl.  The
product was extracted with methylene chloride. The organic layer was washed with
deionized water until all of the DMF was removed. The organic layer was then washed
with brine, dried over magnesium sulfate, filtered, and concentrated in vacuo. The brown
oil was triturated with methanol overnight yielding a white solid (5.2 g, 86% yield). M.P.
= 226-230 °C; 1H NMR (400 MHz CDCl3): δ 6.75 (s, 4 H), δ 6.62 (s, 6 H), δ 4.38 (d, 4
H, J = 13.6 Hz), δ 3.80 (m, 8 H), δ 3.09 (d, 4 H, J = 13.6 Hz), δ 1.89-1.86 (m, 8 H), δ
0.97 (m, 12 Hz); 13C NMR (400 MHz, CDCl3): δ 156.3, 155.7, 137.2, 134.3, 130.7,
128.4, 122.4, 114.7, 76.9, 76.8, 30.8, 23.2, 10.2; HRMS (FAB) Calcd. for C40H46Br2O4










      NMP
reflux, 24 hrs
      58%
CuCN
Synthesis of Dinitrilotetrapropoxycalix[4]arene 1103
Dibromotetrapropoxycalix[4]arene 109 (6.2 g, 1 eq) was dissolved in N-
methylpyrrolidinone (300 mL) in a round bottom flask under nitrogen. Copper (I)
cyanide (4 eq) was added and the reaction was refluxed overnight. After 24 hours, the
reaction was cooled to 100 °C. Iron (III) chloride hexahydrate (4 eq) was dissolved in 1.6
M HCl (300 mL) and heated to 100 °C. The reaction was added to the iron chloride and
stirred for 1 hour. The reaction was cooled to room temperature and filtered to remove
the product.  The product was washed with deionized water. The product was then
dissolved in methylene chloride and precipitated out with methanol (brown solid, 3.1 g,
58% yield). M.P. = 299-302 °C; 1H NMR (400 MHz CDCl3): δ 6.80 (s, 4 H), δ 6.74 (s, 6
H), δ 4.14 (d, 4 H, J = 13.6 Hz), δ 3.87-3.81 (m, 8 H), δ 3.16 (d, 4 H, J = 13.6 Hz), δ
1.90-1.85 (m, 8 H), δ 1.02 (t, 6 H, J = 7.2 Hz), δ 0.93 (t, 6 H, J = 7.6 Hz); 13C NMR (400
MHz, CDCl3): δ 159.7, 156.2, 136.0, 134.4, 131.8, 128.7, 122.8, 105.5, 77.2, 76.8, 30.8,
23.4, 23.2, 10.5, 10.2; HRMS (FAB) Calcd. for C42H46N2O4 (M
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Synthesis of Dicarboxytetrapropoxycalix[4]arene 111
Dinitrilotetrapropoxycalix[4]arene 110 (10.7 g, 1 eq) was dissolved in ethanol
(1.5 L) in a round bottom flask under nitrogen. Potassium hydroxide (1000 eq) was
dissolved in deionized water (500 mL) and added to the reaction. The reaction was then
refluxed overnight. The reaction was monitored by TLC (95:5, CH2Cl2:MeOH). After 24
hours, the reaction was quenched with concentrated HCl (~400 mL) and a white
precipitate formed. The solid was removed by filtration and washed with deionized water.
The solid was then dissolved in methylene chloride and dried over magnesium sulfate.
The solution was then filtered and concentrated in vacuo yielding off white solid (7.5 g,
66% yield). M.P. > 320 °C; 1H NMR (400 MHz CDCl3): δ 7.18 (d, 4 H, J = 7.6 Hz), δ
7.04 (t, 2 H, J = 8.0 Hz), δ 6.77 (s, 4 H), δ 4.43 (d, 4 H, J = 13.6 Hz), δ 4.00 (t, 4 H, J =
8.0 Hz), δ 3.67 (t, 4 H, J = 6.4 Hz), δ 3.16 (d, 4 H, J = 13.6 Hz), δ 1.96-1.84 (m, 8 H), δ
1.11 (t, 6 H, J = 7.2 Hz), δ 0.88 (t, 6 H, J = 7.2 Hz); 13C NMR (400 MHz, CDCl3): δ
172.0, 159.7, 157.5, 136.5, 133.6, 129.6, 129.3, 123.1, 122.8, 76.8, 76.4, 30.8, 23.4, 22.9,
10.8, 9.7; HRMS (FAB) Calcd. for C42H48O8 (M
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Synthesis of Dicarboxydinitrotetrapropoxycalix[4]arene 1122
Dicarboxytetrapropoxycalix[4]arene 111 (6 g, 1 eq) was dissolved in methylene
chloride (750 mL) in a round bottom flask under nitrogen. Concentrated nitric acid (9%
by volume) and glacial acetic acid (6% by volume) were mixed together and then added
to the reaction. The reaction was stirred at room temperature for 2 hours and quenched
with saturated sodium bicarbonate. The organic layer was washed with deionized water
and brine. The organic layer was then dried over magnesium sulfate, filtered, and
concentrated in vacuo. The solid was triturated in methanol overnight to remove some
impurities yielding a yellow solid (4.4 g, 65% yield). M.P. = 298 °C (dec.); 1H NMR (400
MHz DMSO-d6): δ 7.95 (s, OH), δ 7.85 (s, 4 H), δ 7.35 (s, OH), δ 6.80 (s, 4 H), δ 4.37
(d, 4 H, J = 13.9 Hz), δ 4.01 (t, 4 H, J = 8.1 Hz), δ 3.74 (t, 4 H, J = 6.4 Hz), δ 3.40 (d, 4
H, J = 13.9 Hz), δ 1.82-1.87 (m, 8 H), δ 1.08 (t, 6 H, J = 7.3 Hz), δ 0.85 (t, 6 H, J = 7.3
Hz); 13C NMR (400 MHz, DMSO-d6): δ 146.5, 144.2, 127.5, 125.8, 32.7, 31.5; HRMS
(FAB) Calcd. for C42H45N2O12 (M











     MeOH
reflux, 72 hrs
       92%
Synthesis of Dicarboxymethyldinitrotetrapropoxycalix[4]arene 113
Dicarboxydinitrotetrapropoxycalix[4]arene 112 (970 mg, 1 eq) was placed in a
round bottom flask under nitrogen.  Methanol (130 mL) was added and stirred. Sulfuric
acid (20% by volume) was added and the reaction was refluxed. The reaction was
monitored by TLC (95:5, CH2Cl2:MeOH). After 72 hours, the reaction was quenched
with saturated sodium bicarbonate and extracted with methylene chloride. The organic
layer was washed with more saturated sodium bicarbonate, deionized water, and brine.
The organic layer was dried over magnesium sulfate, filtered, and concentrated in vacuo.
A brown crystalline solid was recovered (928 mg, 93% yield). M.P. = 115 °C (dec.); 1H
NMR (400 MHz DMSO-d6): δ 7.70 (s, 4 H), δ 7.09 (s, 4 H), δ 4.34 (d, 4 H, J = 13.9 Hz),
δ 3.97 (t, 4 H, J = 7.7 Hz), δ 3.82 (m, 10 H), δ 3.55 (d, 4 H, J = 13.7 Hz), δ 1.81-1.88 (m,
8 H), δ 1.03 (t, 6 H, J = 7.3 Hz), δ 0.90 (t, 6 H, J = 7.5 Hz); 13C NMR (400 MHz, DMSO-
d6): δ 165.8, 161.1, 160.8, 141.6, 135.4, 135.3, 130.3, 123.8, 122.6, 77.2, 76.7, 55.1, 52.1,
30.1, 23.2, 22.9, 10.6, 10.0; HRMS (FAB) Calcd. for C44H51N2O12 (M
+1): m/z = 799.3442













  2 hrs, 91%
Synthesis of Diaminodicarboxymethyltetrapropoxycalix[4]arene 1142
Dicarboxymethyldinitrotetrapropoxycalix[4]arene 113 (400 mg, 1 eq) was stirred
in methanol (50 mL) in a round bottom flask under nitrogen. The reaction was heated to
60 °C and Raney nickel (cat.) was added. Hydrazine monohydrate (12 eq) was added and
the reaction was stirred rapidly. The reaction was monitored by TLC (95:5,
CH2Cl2:MeOH). After 2 hours, the reaction cooled to room temperature and the Raney
nickel was removed by filtration. The reaction was then concentrated in vacuo (336 mg,
91% yield). M.P. = 123-130 °C; 1H NMR (400 MHz DMSO-d6): δ 7.00 (s, 4 H), δ 6.14
(s, 4 H), δ 4.51 (br s, 4 H), δ 4.23 (d, 4 H, J = 12.8 Hz), δ 3.71 (t, 8 H, J = 6.4 Hz), δ 3.64
(s, 6 H), δ 3.01 (d, 4 H, J = 13.2 Hz), δ 1.78-1.85 (m, 8 H), δ 1.00 (t, 6 H, J = 7.3 Hz), δ
0.87 (t, 6 H, J = 7.3 Hz); 13C NMR (400 MHz, DMSO-d6): δ 168.2, 161.9, 151.0, 142.0,
136.3, 136.2, 130.5, 124.5, 117.7, 78.0, 77.9, 52.2, 32.1, 24.6, 24.3, 11.0, 10.8; HRMS
(FAB) Calcd. for C44H55N2O8 (M
















Synthesis of Dicarboxymethyldifmocglycinotetrapropoxycalix[4]arene 115
Diaminodicarboxymethyltetrapropoxycalix[4]arene 114 (50 mg, 1 eq) was
dissolved in methylene chloride (5 mL) in a round bottom flask under nitrogen. Fmoc-
glycine acid fluoride (5 eq) was added to the reaction and stirred overnight at room
temperature. The reaction was monitored by TLC (95:5, CH2Cl2:MeOH). After 24 hours,
the reaction was concentrated in vacuo and purified by column chromatography
(CH2Cl2:1% MeOH). A tan solid was recovered (39% yield). 
1H NMR (400 MHz
DMSO-d6): δ 9.71 (s, 2 H), δ 7.88 (d, 4 H, J = 7.6 Hz), δ 7.72 (d, 4 H, J = 7.6 Hz), δ 7.41
(t, 4 H, J = 8.0 Hz), δ 7.32 (t, 4 H, J = 7.2 Hz), δ 7.12 (s, 4 H), δ 7.05 (s, 4 H), δ 4.34-
4.23 (m, 10 H), δ 3.80-3.76 (m, 12 H), δ 3.64 (s, 6H), δ 3.20 (d, 4 H, J = 13.6 Hz), δ
1.88-1.82 (m, 8 H), δ 0.99 (t, 6 H, J = 7.2 Hz), δ 0.89 (t, 6 H, J = 7.2 Hz); 13C NMR (400
MHz, DMSO-d6): δ 167.4, 165.7, 159.9, 156.6, 152.3, 143.9, 140.7, 134.7, 134.4, 133.0,
128.8, 127.6, 127.1, 125.3, 123.3, 120.1, 119.7, 76.5, 76.4, 65.7, 51.5, 46.6, 43.9,  30.4,
22.9, 22.5, 10.3, 10.0; HRMS (MALDI) Calcd. for C78H80N4O14 (M
+Na): m/z = 1319.556















Synthesis of Dicarboxydiglycinotetrapropoxycalix[4]arene 103
Dicarboxymethyldifmocglycinotetrapropoxycalix[4]arene 115 (60 mg, 1 eq) was
dissolved in THF (2.5 mL) in a round bottom flask under nitrogen. Methanol (0.25 mL)
was added and stirred. Sodium hydroxide (20 eq) was dissolved in deionized water (1.0
mL) and added to the reaction and stirred at room temperature overnight. The reaction
was monitored by TLC (95:5, CH2Cl2:MeOH). After 24 hours, the reaction was
neutralized with 1 N HCl and concentrated in vacuo. The product was dissolved in a
small amount of methanol and the undissolved salt was removed by filtration. The
methanol was then concentrated in vacuo leaving the product. A tan solid was recovered
(99% yield). M.P. = 265 °C (dec.); 1H NMR (400 MHz CD3OD): δ 7.41 (s, 4 H), δ 6.91
(s, 4 H), δ 4.50 (d, 4 H, J = 13.2 Hz), δ 3.98 (t, 4 H, J = 7.6 Hz), δ 3.86 (t, 4 H, J = 7.2
Hz), δ 3.74 (s, 4 H), δ 3.24 (d, 4 H, J = 13.2 Hz), δ 2.05-1.90 (m, 8 H), δ 1.04 (t, 12 H, J
= 7.2 Hz); 13C NMR (400 MHz, CD3OD): δ 169.7, 162.1, 154.5, 136.4, 136.1, 133.1,
131.4, 127.0, 125.6, 121.8, 120.1, 78.2, 42.1, 31.9, 24.5, 24.4, 10.8, 10.7; HRMS (FAB):
Calcd. for C46H57N4O10 (M
















Synthesis of Dicarboxymethyldifmoc-ß-alaninotetrapropoxycalix[4]arene 116
Diaminodicarboxymethyltetrapropoxycalix[4]arene 114 (50 mg, 1 eq) was
dissolved in methylene chloride (5 mL) in a round bottom flask under nitrogen. Fmoc-ß-
alanine acid fluoride (5 eq) was added to the reaction and stirred overnight at room
temperature. The reaction was monitored by TLC (95:5, CH2Cl2:MeOH). After 24 hours,
the reaction was concentrated in vacuo and purified by column chromatography
(CH2Cl2:1% MeOH). A tan solid was recovered (50% yield).  M.P. = 136 °C (dec.); 
1H
NMR (400 MHz DMSO-d6): δ 9.73 (s, 2 H), δ 7.87 (d, 4 H, J = 7.6 Hz), δ 7.68 (d, 4 H, J
= 7.2 Hz), δ 7.40 (t, 4 H, J = 7.6 Hz), δ 7.30 (t, 4 H, J = 7.2 Hz), δ 7.22 (s, 4 H), δ 6.93 (s,
4 H), δ 4.32-4.12 (m, 10 H), δ 3.82 (t, 4 H, J = 7.2 Hz), δ 3.73 (t, 4 H, J = 6.8 Hz), δ 3.60
(s, 6H), δ 3.29 (t, 4 H, J = 5.6 Hz), δ 3.15 (d, 4 H, J = 13.6 Hz), δ 1.86-1.78 (m, 8 H), δ
1.01 (t, 6 H, J = 7.6 Hz), δ 0.86 (t, 6 H, J = 7.6 Hz); 13C NMR (400 MHz, DMSO-d6): δ
168.8, 165.6, 159.7, 156.1, 152.3, 143.9, 140.7, 134.9, 134.1, 133.4, 128.6, 127.6, 127.1,
125.2, 123.2, 120.1, 119.7, 76.5, 65.4, 51.4, 46.7, 36.9, 36.5, 30.5, 22.9, 22.4, 10.4, 9.9;
HRMS (FAB) Calcd. for C80H85N4O14 (M















 RT, 24 hrs, 99%
Synthesis of Dicarboxydi-ß-alaninotetrapropoxycalix[4]arene 105
Dicarboxymethyldifmoc-ß-alaninotetrapropoxycalix[4]arene 116 (60 mg, 1 eq)
was dissolved in THF (2.5 mL) in a round bottom flask under nitrogen. Methanol (0.25
mL) was added and stirred. Sodium hydroxide (20 eq) was dissolved in deionized water
(1.0 mL) and added to the reaction and stirred at room temperature overnight. The
reaction was monitored by TLC (95:5, CH2Cl2:MeOH). After 24 hours, the reaction was
neutralized with 1 N HCl and concentrated in vacuo. The product was dissolved in a
small amount of methanol and the undissolved salt was removed by filtration. The
methanol was then concentrated in vacuo leaving the product. A tan solid was recovered
(99% yield). M.P. = 245 °C (dec.); 1H NMR (400 MHz CD3OD): δ 7.48 (s, 4 H), δ 6.79
(s, 4 H), δ 4.49 (d, 4 H, J = 13.2 Hz), δ 4.01 (t, 4 H, J = 7.6 Hz), δ 3.82 (t, 4 H, J = 7.6
Hz), δ 3.21-3.24 (m, 8 H), δ 2.69 (t, 4 H, J = 6.0 Hz), δ 1.93-2.01 (m, 8 H), δ 0.99-1.07
(m, 12 H); 13C NMR (400 MHz, CD3OD): δ 170.0, 169.8, 162.4, 154.2, 136.7, 135.7,
133.5, 131.5, 125.5, 121.9, 78.3, 78.2, 37.0, 33.6, 32.0, 24.4, 10.9, 10.6; HRMS (FAB)
Calcd. for C48H61N4O10 (M
















Synthesis of Dicarboxymethyldifmoc-γ-aminobutyric acid-
tetrapropoxycalix[4]arene 117
Diaminodicarboxymethyltetrapropoxycalix[4]arene 114 (50 mg, 1 eq) was
dissolved in methylene chloride (5 mL) in a round bottom flask under nitrogen. Fmoc-γ-
aminobutyric acid fluoride (5 eq) was added to the reaction and stirred at room
temperature overnight. The reaction was monitored by TLC (95:5, CH2Cl2:MeOH). After
24 hours, the reaction was concentrated in vacuo and purified by column chromatography
(CH2Cl2:1% MeOH). A tan solid was recovered (52% yield). M.P. = 127 °C (dec.); 
1H
NMR (400 MHz DMSO-d6): δ 9.65 (s, 2 H), δ 7.87 (d, 4 H, J = 7.6 Hz), δ 7.68 (d, 4 H, J
= 7.6 Hz), δ 7.39 (t, 4 H, J = 8.0 Hz), δ 7.31 (t, 4 H, J = 7.6 Hz), δ 7.20 (s, 4 H), δ 6.93 (s,
4 H), δ 4.32-4.19 (m, 10 H), δ 3.81 (t, 4 H, J = 7.2 Hz), δ 3.73 (t, 4 H, J = 6.8 Hz), δ 3.61
(s, 6H), δ 3.16 (d, 4 H, J = 13.6 Hz), δ 3.02 (q, 4 H, J = 5.6 Hz), δ 2.26 (t, 4 H, J = 7.6
Hz), δ 1.85-1.78 (m, 8 H), δ 1.70 (p, 4 H, J = 6.4 Hz), δ 1.01 (t, 6 H, J = 7.2 Hz), δ 0.85
(t, 6 H, J = 7.2 Hz); 13C NMR (400 MHz, DMSO-d6): δ 170.3, 165.7, 159.7, 156.1, 152.3,
143.9, 140.7, 134.9, 134.1, 133.5, 128.6, 127.6, 127.1, 125.2, 123.2, 120.1, 119.6, 76.5,
155
76.2, 65.2, 51.4, 46.8, 33.6, 30.4, 25.4, 22.9, 22.4, 10.4, 9.9; HRMS (FAB) Calcd. for
C82H89N4O14 (M















Synthesis of Dicarboxydi-γ-aminobutyric acid-tetrapropoxycalix[4]arene 106
Dicarboxymethyldifmoc-γ-aminobutyric acid-tetrapropoxycalix[4]arene 117 (60
mg, 1 eq) was dissolved in THF (2.5 mL) in a round bottom flask under nitrogen.
Methanol (0.25 mL) was added and stirred. Sodium hydroxide (20 eq) was dissolved in
deionized water (1.0 mL) and added to the reaction and stirred at room temperature
overnight. The reaction was monitored by TLC (95:5, CH2Cl2:MeOH). After 24 hours,
the reaction was neutralized with 1 N HCl and concentrated in vacuo. The product was
dissolved in a small amount of methanol and the undissolved salt was removed by
filtration. The methanol was then concentrated in vacuo leaving the product. A tan solid
was recovered (99% yield). M.P. = 240 °C (dec.); 1H NMR (400 MHz CD3OD): δ 7.44
(s, 4 H), δ 6.82 (s, 4 H), δ 4.49 (d, 4 H, J = 13.2 Hz), δ 3.99 (t, 4H, J = 8.0 Hz), δ 3.83 (t,
4 H, J = 7.2 Hz), δ 3.22 (d, 4 H, J = 13.6 Hz), δ 2.98 (t, 4 H, J = 7.2 Hz), δ 2.41 (t, 4 H, J
= 7.2 Hz), δ 1.93-2.00 (m, 12 H), δ 1.00-1.06 (m, 12 H); 13C NMR (400 MHz, CD3OD): δ
172.4, 169.8, 162.3, 154.3, 136.6, 135.8, 135.7, 133.7, 131.4, 125.5, 122.0, 78.2, 40.4,
158
34.4, 32.0, 24.5, 24.4, 24.3, 10.9, 10.7; HRMS (FAB) Calcd. for C50H65N4O10 (M
+1): m/z
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OO
Synthesis of Diethylacetoxycalix[4]arene 14311
Calix[4]arene 93 (9.8 g, 1 eq) and potassium carbonate (3.5 g, 1.1 eq) were placed
in a round bottom flask under nitrogen. Acetonitrile (300 mL) was added and stirred.
Ethyl-bromoacetate (5.7 mL, 2.2 eq) was added and the reaction was refluxed for 24
hours. After cooling to room temperature, the reaction was filtered to remove the
unreacted potassium carbonate. The solution was then concentrated in vacuo. The white
foamy solid was redissolved in methylene chloride and washed with deionized water and
brine. The organic layer was dried over magnesium sulfate, filtered, and concentrated in
vacuo. The off-white solid (15 g) was recrystallized in methanol yielding white crystals
(12.5 g, 91% yield). M.P. = 169-173 °C; 1H NMR (400 MHz CDCl3): δ 7.63 (s, 2 H), δ
7.06 (d, 4 H, J = 7.2 Hz), δ 6.88 (d, 4 H, J = 7.6 Hz), δ 6.72-6.64 (m, 4 H), δ 4.73 (s, 4
H), δ 4.48 (d, 4 H, J = 13.2 Hz), δ 4.32 (q, 4H, J = 6.8 Hz), δ 3.40 (d, 4 H, J = 13.2 Hz), δ
1.33 (t, 6 H. J = 6.8 Hz); 13C NMR (400 MHz, CDCl3): δ 168.8, 152.9, 152.3, 133.0,
129.1, 128.4, 128.0, 125.5, 119.0, 72.4, 61.3, 31.4, 14.0; HRMS (FAB) Calcd. for
C56H57O8 (M













Synthesis of Dibromodiethylacetoxycalix[4]arene 144
Diethylacetoxycalix[4]arene 143 (1 g, 1eq) was dissolved in methylene chloride
(20 mL) in a round bottom flask under nitrogen. N-Bromosuccinamide (650 mg, 2.2 eq)
was added and the reaction was stirred at room temperature overnight. After 24 hours, the
reaction was washed with saturated ammonium chloride, deionized water, and brine. The
organic layer was dried over magnesium sulfate, filtered, and concentrated in vacuo. A
yellow solid was recovered (1.2 g, 92% yield). M.P. = 240 °C (dec.); 1H NMR (400 MHz
CDCl3): δ 7.74 (s, 2 H), δ 7.14 (s, 4 H), δ 6.90 (d, 4 H, J = 7.6 Hz), δ 6.80-6.78 (m, 4 H),
δ 4.68 (s, 4 H), δ 4.41 (d, 4 H, J = 13.2 Hz), δ 4.31 (q, 4H, J = 7.2 Hz), δ 3.31 (d, 4 H, J =
13.2 Hz), δ 1.32 (t, 6 H. J = 7.6 Hz); 13C NMR (400 MHz, CDCl3): δ 168.7, 152.4, 152.0,
132.5, 130.8, 130.1, 129.4, 125.8, 110.6, 72.3, 61.4, 31.2, 14.1; HRMS (FAB) Calcd. for
C56H54O8Br2 (M
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reflux, 48 hrs
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Synthesis of Dibromotetraethylacetoxycalix[4]arene 14511
Dibromodiethylacetoxycalix[4]arene 144 (2.1 g, 1 eq) and sodium acetate (3.0 g,
10 eq) were added to a round bottom flask under nitrogen. Acetonitrile (40 mL) was
added and the reaction was stirred. Ethyl-bromoacetate (3.1 mL, 10 eq) was added and
the reaction was refluxed. After 48 hours, the reaction was cooled to room temperature
and filtered to remove the unreacted sodium carbonate. The solution was concentrated in
vacuo. The red oil was redissolved in methylene chloride. Deionized water was added
and vigorously stirred overnight to remove any dissolved sodium carbonate. The organic
layer was separated and  dried over magnesium sulfate. The organic layer was filtered
and concentration in vacuo and recrystallized in methylene chloride/methanol. The
yellow crystals (1.5 g, 58% yield) were dried in vacuo. M.P. = 131-133 °C; 1H NMR
(400 MHz CDCl3): δ 6.84 (s, 4 H), δ 6.62 (s, 6 H), δ 4.83 (d, 4 H, J = 13.6 Hz), δ 4.70 (s,
4 H), δ 4.66 (s, 4 H), δ 4.18 (q, 4H, J = 7.2 Hz), δ 3.18 (d, 4 H, J = 13.6 Hz), δ 1.27 (t, 12
H. J = 6.8 Hz); 13C NMR (400 MHz, CDCl3): δ 169.9, 155.6, 155.1, 136.9, 133.7, 131.2,
128.7, 123.4, 115.6, 71.3, 71.2, 60.6, 60.6, 31.3, 14.2; HRMS (FAB) Calcd. for
C44H46O12Br2 (M
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Synthesis of Dibromotetrahydroxyethylcalix[4]arene 14112
Dibromotetraethylacetoxycalix[4]arene 145 (500 mg, 1 eq) was dissolved in
anhydrous THF (10 mL) in a round bottom flask under nitrogen. Borane-methyl sulfide
complex (2M, 2 mL, 7.5 eq) was added dropwise and while the reaction was stirred.
After addition of the borane-methyl sulfide complex, the reaction was refluxed and
monitored by TLC (10:1, CH2Cl2:MeOH). After 3 hours, the reaction was cooled to room
temperature and quenched slowly with saturated sodium carbonate with lots of bubbling.
The solution was then acidified with concentrated hydrochloric acid and the product was
extracted with methylene chloride. The organic layer was dried over magnesium sulfate,
filtered, and concentrated in vacuo. The crude product (390 mg) was purified by column
chromatography (CH2Cl2/ 5% methanol) to give an off-white solid (250 mg, 61% yield).
M.P. 127 °C (dec.); 1H NMR (400 MHz CDCl3): δ 6.86 (s, 4 H), δ 6.69 (s, 6 H), δ 4.33
(d, 4 H, J = 13.6 Hz), δ 3.97 (s, 4 H), δ 3.93 (s, 4 H), δ 3.20 (d, 4 H, J = 13.6 Hz; 13C
NMR (400 MHz, CDCl3): δ 154.8, 154.2, 136.8, 133.7, 131.4, 129.0, 123.8, 116.1, 78.0,
78.0, 61.5, 61.4, 30.1; HRMS (FAB) Calcd. for C36H39O8Br2 (M
+1): m/z =  757.1011
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